• FindZebra
  • About
  • Contact
  • Help
  • Login
Advanced
  • Progressive Osseous Heteroplasia Wikipedia
    External links [ edit ] Classification D OMIM : 166350 MeSH : C562735 DiseasesDB : 34694 v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins This dermatology article is a stub .
    GNAS, ACVR1, RUNX2, PTH
    • Progressive Osseous Heteroplasia Orphanet
      Progressive osseous heteroplasia (POH) is a rare genetic bone disorder characterized clinically by progressive extraskeletal bone formation presenting in early life with cutaneous ossification, that progressively involves subcutaneous and then subsequently deep connective tissues, including muscle and fascia. POH overlaps with a number of related genetic disorders including Albright hereditary osteodystrophy, pseudohypoparathyroidism (see these terms), and primary osteoma cutis, that share the common features of superficial heterotopic ossification in association with inactivating mutations of GNAS gene (20q13.2-q13.3), coding for guanine nucleotide-binding proteins. POH can, however, be distinguished clinically by the deep and progressive nature of the heterotopic bone formation.
    • Progressive Osseous Heteroplasia GARD
      Progressive osseous heteroplasia (POH) is a progressive bone disorder in which bone forms (ossifies) within skin and muscle tissue. It usually becomes apparent in infancy with skin (cutaneous) ossification, which progresses to involvement of subcutaneous and deep tissues, including muscle. In some cases, it first becomes apparent later in childhood or in early adulthood. Ossification may cause pain and open sores (ulcers) in affected areas of the body. Joints may become involved over time, causing impaired mobility. POH is caused by a mutation in the GNAS gene and is inherited in an autosomal dominant manner.
    • Osteoma Cutis Wikipedia
      Osteoma cutis Other names POH [1] Perforating osteoma cutis, skin of the foot Specialty Oncology , dermatology Osteoma cutis is a cutaneous condition characterized by the presence of bone within the skin in the absence of a preexisting or associated lesion. [2] : 529 See also [ edit ] Calcinosis cutis Skin lesion List of cutaneous conditions References [ edit ] ^ "OMIM Entry - # 166350 - OSSEOUS HETEROPLASIA, PROGRESSIVE; POH" . omim.org . Retrieved 18 April 2019 . ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology . Saunders Elsevier. ISBN 978-0-7216-2921-6 . External links [ edit ] Classification D ICD - 10 : D23 ( ILDS D23.L79) OMIM : 166350 External resources eMedicine : article/1103575 Orphanet : 2762 This cutaneous condition article is a stub . You can help Wikipedia by expanding it . v t e
    • Osseous Heteroplasia, Progressive OMIM
      McKusick (1989) observed osteoma cutis in a 38-year-old man who also had unerupted teeth, severe bilateral carpal tunnel syndrome, and unusual changes in the bones of the forearms and legs that were quite different from those of pseudohypoparathyroidism. ... Based on clinical criteria, they concluded that POH and progressive HO syndromes are at the severe end of a phenotypic spectrum of GNAS-inactivating conditions associated with extraskeletal ossification and that they can be distinguished from other GNAS-based disorders by a single clinical parameter, i.e., the extension of HO from superficial to deep tissue.
    • Progressive Osseous Heteroplasia MedlinePlus
      Progressive osseous heteroplasia is a disorder in which bone forms within skin and muscle tissue. Bone that forms outside the skeleton is called heterotopic or ectopic bone. In progressive osseous heteroplasia, ectopic bone formation begins in the deep layers of the skin (dermis and subcutaneous fat) and gradually moves into other tissues such as skeletal muscle and tendons. The bony lesions within the skin may be painful and may develop into open sores (ulcers). Over time, joints can become involved, resulting in impaired mobility.
  • Lipomatosis Wikipedia
    Removal can include simple excision, endoscopic removal, or liposuction. [1] Other entities which are accompanied by multiple lipomas include Proteus syndrome , Cowden syndrome and related disorders due to PTEN gene mutations, benign symmetric lipomatosis ( Madelung disease ), Dercum's Disease, familial lipodystrophy , hibernomas , epidural steroid injections with epidural lipomatosis, [6] and familial angiolipomatosis. ... omim+151900 Lipomatosis, Familial Multiple Lipomatosis, FML ^ https://www.biomedcentral.com/1471-2253/14/70 Multiple Epidural Steroid Injections and Epidural Lipomatosis External links [ edit ] Classification D ICD - 10 : E88.2 OMIM : 151900 MeSH : D008068 SNOMED CT : 37095002 v t e Inborn error of lipid metabolism : dyslipidemia Hyperlipidemia Hypercholesterolemia / Hypertriglyceridemia Lipoprotein lipase deficiency/Type Ia Familial apoprotein CII deficiency/Type Ib Familial hypercholesterolemia/Type IIa Combined hyperlipidemia/Type IIb Familial dysbetalipoproteinemia/Type III Familial hypertriglyceridemia/Type IV Xanthoma/Xanthomatosis Hypolipoproteinemia Hypoalphalipoproteinemia/HDL Lecithin cholesterol acyltransferase deficiency Tangier disease Hypobetalipoproteinemia/LDL Abetalipoproteinemia Apolipoprotein B deficiency Chylomicron retention disease Lipodystrophy Barraquer–Simons syndrome Other Lipomatosis Adiposis dolorosa Lipoid proteinosis APOA1 familial renal amyloidosis
    PTEN, PIK3CA, CEL, MTOR, KRAS, MEN1, ABCB1, PIK3CB, PIK3CD, PIK3CG, HNF1B, HMGA2, MFN2, PNPLA6, TBC1D9, TBL1XR1
  • Cronkhite-Canada Syndrome Orphanet
    Cronkhite-Canada syndrome (CCS) is a rare gastrointestinal (GI) polyposis syndrome characterized by the association of non-hereditary GI polyposis with the cutaneous triad of alopecia, nail changes and hyperpigmentation. ... Differential diagnosis Differential diagnosis includes familial adenomatous polyposis, hyperplastic polyposis syndrome, cap polyposis, juvenile polyposis syndrome, Peutz-Jeghers syndrome and Cowden syndrome (see these terms), as well as lipomatous polyposis, inflammatory polyposis and lymphomatous polyposis.
    STK11, PTEN
    • Cronkhite–canada Syndrome Wikipedia
      Cronkhite–Canada syndrome Other names Gastrointestinal polyposis-skin pigmentation-alopecia-fingernail changes syndrome Cronkhite–Canada syndrome affects the digestive tract Specialty Gastroenterology Cronkhite–Canada syndrome is a rare syndrome characterized by multiple polyps of the digestive tract . ... Recent findings have called this hypothesis into question; specifically, the hair and nail changes may not improve with improved nutrition. [ citation needed ] Other conditions consisting of multiple hamartomatous polyps of the digestive tract include Peutz–Jeghers syndrome , juvenile polyposis , and Cowden disease . Related polyposis conditions are familial adenomatous polyposis , attenuated familial adenomatous polyposis , Birt–Hogg–Dubé syndrome and MUTYH . [ citation needed ] Diagnosis [ edit ] There is no specific test to diagnose Cronkhite–Canada syndrome. ... "Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia". ... PMID 12868681 . ^ "Cronkhite-Canada Syndrome" . NORD (National Organization for Rare Disorders) .
    • Cronkhite-Canada Disease GARD
      Cronkhite-Canada syndrome is a rare gastrointestinal disorder characterized by widespread colon polyps , unhealthy looking (dystrophic) nails, hair loss ( alopecia ), darkening skin (such as on the hands, arms, neck and face), diarrhea, weight loss, stomach pain, and/or excess fluid accumulation in arms and legs (peripheral edema).
    • Polyposis, Skin Pigmentation, Alopecia, And Fingernail Changes OMIM
      Description Cronkhite-Canada syndrome is characterized by gastrointestinal hamartomatous polyposis, alopecia, onychodystrophy, skin hyperpigmentation, and diarrhea. ... Clinical Features Cronkhite and Canada (1955) described 2 unrelated patients with a syndrome of gastrointestinal polyposis, skin hyperpigmentation, alopecia, onychodystrophy, and diarrhea. ... The pigmentation is diffuse rather than spotted as in the Peutz-Jeghers syndrome (175200). Sweetser et al. (2012) described 14 consecutive cases of Cronkhite-Canada syndrome seen at the Mayo Clinic on whom tissue and follow-up were available. ... Inheritance Sweetser et al. (2012) stated that 'Cronkhite-Canada syndrome...is a noninherited condition.'
  • Brooke-Spiegler Syndrome Orphanet
    A rare genetic disease characterized as an inherited skin tumour predisposition syndrome presenting with skin appendage tumours, namely cylindromas, spiradenomas and trichoepitheliomas Epidemiology To date, more than 200 cases of CYLD Cutaneous Syndrome (CCS) have been reported in the literature. ... Differential diagnosis Differential clinical diagnosis for multiple skin and/or scalp tumours include Birt-Hogg-Dubé syndrome, neurofibromatosis type 1, Cowden syndrome, tuberous sclerosis complex, Marie-Unna hypotrichosis, basal cell naevus syndrome, pilar cysts, multiple syringomas.
    CYLD, GP1BA, GP9, GP1BB, GCG, FGFR2, NLRP3, NOD2, EGF, AHSA1, GRAP2, BCL2, PNPLA6, AIMP2, WNT5A, VWF, ADIPOQ, POLDIP2, RNF19A, TAPBP, DKK3, SPINK4, XYLT1, EHMT1, GFM1, TP53, MAPK1, SLC15A1, RYR1, CASP1, CDK7, CRK, MAPK14, DPP4, SLC26A3, GH1, GLP1R, IGF1, IGFBP4, IL1B, LBP, ODC1, C3, RPS19, ZGLP1
    • Cyld Cutaneous Syndrome GARD
      CYLD cutaneous syndrome causes the growth of several types of non-cancerous (benign) skin tumors. ... The types of tumors that occur in CYLD cutaneous syndrome may include cylindromas , spiradenomas , and trichoepitheliomas . ... Other complications may include an increased risk to develop basal cell cancer of the salivary gland or deafness due to the growth of a tumor in the ear canal. CYLD cutaneous syndrome is caused by genetic variants in the CYLD gene and is inherited in an autosomal dominant pattern. Diagnosis of CYLD cutaneous syndrome is based on the symptoms, clinical exam, and microscopic exam of the tumor tissue. ... The conditions known as Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma are now recognized to be part of CYLD cutaneous syndrome.
    • Cyld Cutaneous Syndrome MedlinePlus
      CYLD cutaneous syndrome is a genetic condition characterized by the growth of multiple noncancerous (benign) skin tumors. ... While the skin tumors associated with CYLD cutaneous syndrome are typically benign, occasionally they may become cancerous (malignant). ... For reasons that are unclear, females with CYLD cutaneous syndrome tend to develop more tumors than males with this condition. ... CYLD cutaneous syndrome includes the conditions previously called Brooke-Spiegler syndrome, multiple familial trichoepithelioma, and familial cylindromatosis. ... Frequency The prevalence of CYLD cutaneous syndrome is unknown, but the condition is estimated to affect more than 1 in 100,000 individuals.
    • Brooke-Spiegler Syndrome OMIM
      A number sign (#) is used with this entry because Brooke-Spiegler syndrome (BRSS) is caused by heterozygous mutation in the CYLD gene (605018) on chromosome 16q12. ... Blake and Toro (2009) provided a review of Brooke-Spiegler syndrome and pathogenic mutations in the CYLD gene. ... Weyers et al. (1993) reported a patient with Brooke-Spiegler syndrome in whom spiradenomas were found in the immediate vicinity of trichoepitheliomas and in continuity with follicles. ... Nasti et al. (2009) reported an Italian mother and son with variable manifestations of Brooke-Spiegler syndrome. The 79-year-old mother began developing skin lesions at age 16. ... History Weyers et al. (1993) noted that Brooke-Spiegler syndrome is named eponymically after the 2 physicians who first reported these neoplasms, Henry G.
  • Proteus Syndrome MedlinePlus
    Proteus syndrome is a rare condition characterized by overgrowth of the bones, skin, and other tissues. ... Pulmonary embolism is a common cause of death in people with Proteus syndrome. Frequency Proteus syndrome is a rare condition with an incidence of less than 1 in 1 million people worldwide. ... Researchers believe that Proteus syndrome may be overdiagnosed, as some individuals with other conditions featuring asymmetric overgrowth have been mistakenly diagnosed with Proteus syndrome. ... Instead, these individuals actually have condition that is considered part of a larger group of disorders called PTEN hamartoma tumor syndrome. One name that has been proposed for the condition is segmental overgrowth, lipomatosis, arteriovenous malformations, and epidermal nevus (SOLAMEN) syndrome; another is type 2 segmental Cowden syndrome. However, some scientific articles still refer to PTEN -related Proteus syndrome. Learn more about the gene associated with Proteus syndrome AKT1 Inheritance Pattern Because Proteus syndrome is caused by AKT1 gene mutations that occur during early development, the disorder is not inherited and does not run in families.
    PTEN, AKT1, PIK3CA, PITX2, TSC1, THBD, LEFTY2, SELP, SELE, PIK3CG, FGFR3, PIK3CD, PIK3CB, NOTCH3, MYOG, GPC3, TSC2
    • Proteus Syndrome GeneReviews
      Summary Clinical characteristics. Proteus syndrome is characterized by progressive segmental or patchy overgrowth most commonly affecting the skeleton, skin, adipose, and central nervous systems. ... Diagnosis Suggestive Findings Proteus syndrome (PS) should be suspected in a proband with the following. ... Clinical Characteristics Clinical Description Proteus syndrome (PS) displays a wide range of severity. ... A phenotypic subtype, described as type II segmental Cowden syndrome [Happle 2007] or SOLAMEN syndrome [Caux et al 2007], is the consequence of a germline pathogenic variant in PTEN with a somatic, mosaic second PTEN variant that gives the phenotype its segmental attributes. ... Klippel-Trenaunay syndrome is a disorder that manifests both overgrowth and vascular malformations.
    • Proteus Syndrome OMIM
      Cohen (2014) provided a detailed review of the clinical features, diagnosis, and management issues of Proteus syndrome. Some authors (Zhou et al. (2000, 2001); Smith et al., 2002) have reported a 'Proteus-like' syndrome associated with germline and tissue-specific somatic mutations in the PTEN gene (601728), which is mutated in Cowden syndrome (CWS1); see 158350 for a discussion of these patients. ... The disorder might be confused with the Klippel-Trenaunay-Weber syndrome (149000) and with Ollier disease (166000) and Maffucci syndrome (614569). ... Some similarities to the Bannayan-Zonana syndrome (see 153480) and linear sebaceous nevus syndrome (163200) were noted. ... He suggested this mechanism also for Schimmelpenning-Feuerstein-Mims syndrome (163200) and the McCune-Albright syndrome (174800). ... See encephalocraniocutaneous lipomatosis (ECCL; 613001), which shares many features with Proteus syndrome. Elattoproteus Syndrome Happle (1999) suggested the designation elattoproteus syndrome for a disorder that he considered to be an inverse form of Proteus syndrome.
    • Proteus Syndrome Orphanet
      Proteus syndrome (PS) is a very rare and complex hamartomatous overgrowth disorder characterized by progressive overgrowth of the skeleton, skin, adipose, and central nervous systems. ... Etiology Causal mutations of PS have been reported in two components of the phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway: PTEN , which make PS a part of the PTEN Hamartoma Tumor Syndrome (PTHS; see this term) and AKT1 . ... If these criteria are not met then a patient may be diagnosed with Proteus-like syndrome (see this term). Molecular genetic testing may confirm diagnosis. Differential diagnosis Differential diagnoses include Klippel-Trenaunay-Weber syndrome, hemihypertrophy, Ollier disease, macrodactyly, Maffucci syndrome, CLOVE syndrome, neurofibromatosis type 1 and other PHTS disorders (see these terms).
    • Proteus Syndrome GARD
      Proteus syndrome is characterized by excessive growth of a part or portion of the body. The overgrowth is usually asymmetric, which means it affects the right and left sides of the body differently. Newborns with Proteus syndrome have few or no signs of the disorder. ... It may result in differences in appearance and with time, an increased risk for blood clots and tumors. Some people with Proteus syndrome have neurological abnormalities, including intellectual disability, seizures, and vision loss, as well as distinctive facial features. Proteus syndrome is caused by a change (mutation) in the AKT1 gene. ... This is why only a portion of the body is affected and why individuals with Proteus syndrome can be very differently affected.
  • Metachondromatosis Wikipedia
    Metachondromatosis is an autosomal dominant , [2] incompletely penetrant [3] skeletal disorder affecting the growth of bones , leading to multiple enchondromas and osteochondromas . [3] This tumor syndrome affects mainly tubular bones, though it can also involve the vertebrae, small joints, and flat bones. [4] Contents 1 Genetics 2 Diagnosis 3 Treatment 4 References 5 External links Genetics [ edit ] Metachondromatosis is inherited in an autosomal dominant manner. [3] This means that the defective gene responsible for a disorder is located on an autosome , and only one copy of the gene is sufficient to cause the disorder, when inherited from a parent who has the disorder. ... External links [ edit ] Classification D ICD - 10 : Q78.4 OMIM : 156250 MeSH : C562938 DiseasesDB : 32116 External resources Orphanet : 2499 v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins This genetic disorder article is a stub .
    PTPN11, DPEP1, EXT1, EXT2, IHH
    • Metachondromatosis OMIM
      A number sign (#) is used with this entry because of evidence that metachondromatosis (METCDS) is caused by heterozygous mutation in the PTPN11 gene (176876) on chromosome 12q24. Description Metachondromatosis is characterized by exostoses (osteochondromas), commonly of the hands and feet, and enchondromas of long bone metaphyses and iliac crests (summary by Sobreira et al., 2010). Clinical Features Maroteaux (1971) described 2 families with skeletal radiologic features of both multiple exostoses (133700) and Ollier disease (166000). He called the disorder metachondromatosis and suggested autosomal dominant inheritance on the basis of 1 family with 5 affected persons. Lachman et al. (1974) reported a case. Kennedy (1983) presented the case of a 9.5-year-old boy in whom 'bumps' on the hands, feet and knees had been noted at age 5.
    • Metachondromatosis Orphanet
      Other diseases to be considered include the non-hereditary conditions Ollier disease and Maffucci syndrome (in which multiple enchondromas are found in the medulla of the bone and are predominantly unilateral), and dysplasia epiphysealis hemimelica (DEH; characterized by a cartilaginous overgrowth mainly located in the lower extremities on one side of the body) (see these terms).
    • Metachondromatosis GARD
      Metachondromatosis (MC) is a rare bone disorder characterized by the presence of both multiple enchondromas and osteochondroma -like lesions. The first signs occur during the first decade of life. Osteochondromas most commonly occur in the hands and feet (predominantly in digits and toes), and enchondromas involve the iliac crests and metaphyses of long bones. The lesions typically spontaneously decrease in size or regress. Nerve paralysis or vascular complications may occur in some cases. The condition has been linked to mutations in the PTPN11 gene in several families and is inherited in an autosomal dominant manner. Treatment may include surgery to remove osteochondromas in severe cases.[8171]
  • Benign Tumor Wikipedia
    Insulinomas can produce large amounts of insulin, causing hypoglycemia . [8] [9] Pituitary adenomas can cause elevated levels of hormones such as growth hormone and insulin-like growth factor-1 , which cause acromegaly ; prolactin ; ACTH and cortisol , which cause Cushings disease ; TSH , which causes hyperthyroidism ; and FSH and LH . [10] Bowel intussusception can occur with various benign colonic tumors. [11] Cosmetic effects can be caused by tumors, especially those of the skin, possibly causing psychological or social discomfort for the person with the tumor. [12] Vascular tissue tumors can bleed, in some cases leading to anemia . [13] Causes [ edit ] PTEN hamartoma syndrome [ edit ] PTEN hamartoma syndrome consists of four distinct hamartomatous disorders characterised by genetic mutations in the PTEN gene; Cowden syndrome , Bannayan-Riley-Ruvalcaba syndrome , Proteus syndrome and Proteus-like syndrome . ... Absent or dysfunctional PTEN protein allows cells to over-proliferate, causing hamartomas. [14] Other syndromes [ edit ] Cowden syndrome is an autosomal dominant genetic disorder characterised by multiple benign hamartomas ( trichilemmomas and mucocutaneous papillomatous papules) as well as a predisposition for cancers of multiple organs including the breast and thyroid. [15] [16] Bannayan-Riley-Ruvalcaba syndrome is a congenital disorder characterised by hamartomatous intestinal polyposis, macrocephaly , lipomatosis , hemangiomatosis and glans penis macules. [14] [17] Proteus syndrome is characterised by nevi , asymmetric overgrowth of various body parts, adipose tissue dysregulation, cystadenomas , adenomas , vascular malformation. [18] [19] Endoscopic image of sigmoid colon of a patient with familial adenomatous polyposis . ... PMID 19668082 . ^ Pilarski R, Eng C (May 2004). "Will the real Cowden syndrome please stand up (again)? ... PMID 15121767 . ^ Eng C (November 2000). "Will the real Cowden syndrome please stand up: revised diagnostic criteria" . ... PMID 11073535 . ^ Eng C (September 2003). "PTEN: one gene, many syndromes". Hum. Mutat . 22 (3): 183–98. doi : 10.1002/humu.10257 .
    HMGA2, CDKN2A, VEGFA, MYC, AKR1B10, TOP1, SST, MSLN, PTGS2, BRCA1, ERCC1, ABCB1, FASN, LCN2, NQO1, GLP1R, CSF1R, PDIA3, GSTT1, HSF1, TERT, SRF, ID1, SOD2, SLC5A5, SKP2, KRAS, IL1B, IL2, E2F1, PPARA, PLAUR, KDM6A, NOS3, EPHA2, IL18, KCNH2, LTF, NAT1, ATF2, VDR, PLEKHS1, ATM, SNORD50A, DNAJC10, WDR74, BIRC6, LIN28A, NACC1, ENOX2, AHR, APOBEC3A, LIN28B, MIR129-2, SNORD50B, OCLN, ARHGAP45, GPX3, CAT, YY1, APOBEC3B, GPR55, TNFRSF10A, CAPN1, CITED2, GSTO1, TRPV1, DLC1, ASIP, TP53, TSC2, NF2, NME1, BRAF, MUC16, EGFR, CCND1, ERBB2, COX8A, IGF2, PTEN, SMARCB1, IGF1, MDM2, TSC1, SMUG1, H3P10, ESR2, FOLH1, RET, MGMT, CTSB, MIB1, HSP90AA1, HNF1A, NF1, TAS2R38, F9, SSX2, PTCH1, HP, CYP19A1, IL6, CXCL8, MMP13, DAPK1, MMP9, KRT20, CEACAM5, TOP2A, COPS5, CDKN2B, PLAG1, PAX8, SERPINE1, GH1, CCDC6, ADAM12, RASSF1, SSX2B, CTNNB1, MIR21, EGF, MTOR, HMGA1, MIR106B, NPY, STIP1, SEMA4F, DICER1, HPSE, SEMA4D, VSIG4, BCL2, BSG, TUBB3, BTG1, BTG3, AKR1A1, CCNG1, FLOT1, SIRT1, PDLIM7, ABI1, KLK4, PCAP, SCG2, REEP5, TFPI2, NCOA4, FGF23, CUL1, RGS5, CBX4, AKR7A2, RIPK1, ADAM9, TNFRSF6B, TNFRSF11A, CDKN1C, KAT2B, SOCS3, CLDN1, USP6, P2RX6, KIF1A, CDH1, NTN1, CD68, GDF15, NPEPPS, BAG3, BCAR1, CD44, BAK1, CD274, TRIM29, MIR17, AKT1, HT, RAB40A, CNTN4, ZNF367, AFP, THSD7A, RAB40AL, ADH6, C17orf97, LINC01194, MIR10B, ADH4, MIR15A, MIR187, CLIC4, MIR200A, MIR211, MIR23B, MIR17HG, MIR372, MIR373, MIR375, NME1-NME2, ADH1C, SYCE1L, CD24, ADH1B, TMX2-CTNND1, MTCO2P12, HTRA3, AKR1B1, TBRG1, ING5, AQP6, DKK2, RPS6KA6, RABGEF1, HTRA2, IGHV1-12, PSAT1, STOML2, LEF1, IGF2-AS, GDE1, MED15, AQP5, AQP1, SYTL2, BCOR, ANO1, FBXW7, KLK15, KLK3, BIRC5, KLHL1, CPAT1, ELAC2, GAS5, SOX17, RHBDF2, APC, ANXA2, PRDM2, FOSB, WNT5A, CENPF, EXT2, ILK, INSRR, MECOM, KDR, KIT, ETV4, KRT19, ETS1, LGALS3BP, LMNA, LMX1A, LPP, LTBP2, MCAM, ESR1, MEN1, MET, MELTF, MIF, MKI67, MLH1, MMP7, MMP14, COX2, ERG, NDUFAB1, EPHB3, NFE2L2, IL17A, IL16, EZH2, HIF1A, FUS, GABPA, KAT2A, GFAP, GLI1, GLI2, FOS, CXCR3, FN1, FOXM1, HDAC1, HDC, HGF, HLA-DRB1, F3, HOXA7, HOXD8, HPR, HPT, HPV18I2, HRAS, FGFR2, TNC, ICAM1, FBLN1, FAP, IGFBP2, IGFBP3, EIF4E, NME2, NOS1, TGFB1, DNMT3A, SLC2A1, DDIT3, DCN, SNAI1, SOX1, SPP1, SRD5A2, CTSL, SS18, STAT3, TCF7, TG, THBD, SRSF3, TIMP1, TIMP2, CTNND1, TPO, CSE1L, CLDN4, TSHR, TTR, ABCC2, CCR7, CCR5, VIM, VIPR1, SGTA, SFRP1, NOTCH3, PPP2R1B, NRAS, TNFRSF11B, PAX1, PAX3, PCNA, PDGFRB, SERPINF1, EDNRB, PLAU, EDNRA, PLXNA2, POMC, EDN1, ADH1A, SEMG2, PROS1, LPAR1, PTH, DUSP6, PTPRC, RAD51B, RAP1GAP, S100A4, S100A6, S100A12, CCL2, CCL18, SEMA3F, PRKCD
  • Juvenile Primary Lateral Sclerosis Wikipedia
    External links [ edit ] Genetics Home Reference – JPLS Classification D ICD - 10 : G12.2 OMIM : 606353 MeSH : C536416 External resources Orphanet : 247604 v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    ALS2, ERLIN2
    • Primary Lateral Sclerosis, Juvenile OMIM
      A number sign (#) is used with this entry because of evidence that juvenile primary lateral sclerosis (PLSJ) is caused by homozygous mutation in the gene encoding alsin (ALS2; 606352) on chromosome 2q33. Juvenile amyotrophic lateral sclerosis-2 (205100) and infantile-onset ascending spastic paralysis (IAHSP; 607225) are allelic disorders with overlapping phenotypes. See also adult-onset PLS (611637), which occurs sporadically or shows autosomal dominant inheritance. Description Although primary lateral sclerosis is similar to amyotrophic lateral sclerosis (ALS; 105400), they are considered to be clinically distinct progressive paralytic neurodegenerative disorders. Following a period of diagnostic confusion, the clinical distinction between ALS and PLS became clear and diagnostic criteria established (Pringle et al., 1992).
    • Juvenile Primary Lateral Sclerosis Orphanet
      A very rare motor neuron disease characterized by progressive upper motor neuron dysfunction leading to loss of the ability to walk with wheelchair dependence, and subsequently, loss of motor speech production. Epidemiology The prevalence and incidence of JPLS are not known. A very small number of cases have been reported to date with this condition. The disorder has been described in various ethnic groups. Clinical description Affected patients are usually normal at birth and have normal early development. During the second year of life, they lose the ability to walk (some patients never walk due to early severe spasticity) and then develop slowly progressive upper motor neuron disorders including pseudobulbar palsy and spastic quadriplegia. Other signs include clumsiness, muscle weakness and balance difficulties.
    • Juvenile Primary Lateral Sclerosis GARD
      Juvenile primary lateral sclerosis is a rare disorder characterized by progressive weakness and stiffness of muscles in the arms, legs, and face. This disorder damages motor neurons, which are specialized nerve cells in the brain and spinal cord that control muscle movement. Symptoms begin in early childhood and progress over a period of 15 to 20 years. Juvenile primary lateral sclerosis is caused by mutations in the ALS2 gene. It is inherited in an autosomal recessive pattern.
    • Juvenile Primary Lateral Sclerosis MedlinePlus
      Juvenile primary lateral sclerosis is a rare disorder characterized by progressive weakness and tightness (spasticity) of muscles in the arms, legs, and face. The features of this disorder are caused by damage to motor neurons, which are specialized nerve cells in the brain and spinal cord that control muscle movement. Symptoms of juvenile primary lateral sclerosis begin in early childhood and progress slowly over many years. Early symptoms include clumsiness, muscle weakness and spasticity in the legs, and difficulty with balance. As symptoms progress, the spasticity spreads to the arms and hands and individuals develop slurred speech, drooling, difficulty swallowing, and an inability to walk.
  • Angiomatosis Wikipedia
    Symptoms may include headaches, problems with balance and walking, dizziness, weakness of the limbs, vision problems and high blood pressure. [4] Bacillary angiomatosis Klippel-Trenaunay-Weber syndrome Sturge-Weber syndrome Histology [ edit ] It is a vascular malformation wherein blood vessels proliferate along with accompanying mature fat and fibrous tissue , lymphatics and sometimes nerves . [2] They may involve skin , subcutaneous tissue , skeletal muscle and occasionally bone . [2] Diagnosis [ edit ] This section is empty. ... External links [ edit ] Classification D MeSH : D000798 SNOMED CT : 205562004 External resources eMedicine : article/1051846 v t e Cardiovascular disease (vessels) Arteries , arterioles and capillaries Inflammation Arteritis Aortitis Buerger's disease Peripheral artery disease Arteriosclerosis Atherosclerosis Foam cell Fatty streak Atheroma Intermittent claudication Critical limb ischemia Monckeberg's arteriosclerosis Arteriolosclerosis Hyaline Hyperplastic Cholesterol LDL Oxycholesterol Trans fat Stenosis Carotid artery stenosis Renal artery stenosis Other Aortoiliac occlusive disease Degos disease Erythromelalgia Fibromuscular dysplasia Raynaud's phenomenon Aneurysm / dissection / pseudoaneurysm torso : Aortic aneurysm Abdominal aortic aneurysm Thoracic aortic aneurysm Aneurysm of sinus of Valsalva Aortic dissection Aortic rupture Coronary artery aneurysm head / neck Intracranial aneurysm Intracranial berry aneurysm Carotid artery dissection Vertebral artery dissection Familial aortic dissection Vascular malformation Arteriovenous fistula Arteriovenous malformation Telangiectasia Hereditary hemorrhagic telangiectasia Vascular nevus Cherry hemangioma Halo nevus Spider angioma Veins Inflammation Phlebitis Venous thrombosis / Thrombophlebitis primarily lower limb Deep vein thrombosis abdomen Hepatic veno-occlusive disease Budd–Chiari syndrome May–Thurner syndrome Portal vein thrombosis Renal vein thrombosis upper limb / torso Mondor's disease Paget–Schroetter disease head Cerebral venous sinus thrombosis Post-thrombotic syndrome Varicose veins Gastric varices Portacaval anastomosis Caput medusae Esophageal varices Hemorrhoid Varicocele Other Chronic venous insufficiency Chronic cerebrospinal venous insufficiency Superior vena cava syndrome Inferior vena cava syndrome Venous ulcer Arteries or veins Angiopathy Macroangiopathy Microangiopathy Embolism Pulmonary embolism Cholesterol embolism Paradoxical embolism Thrombosis Vasculitis Blood pressure Hypertension Hypertensive heart disease Hypertensive emergency Hypertensive nephropathy Essential hypertension Secondary hypertension Renovascular hypertension Benign hypertension Pulmonary hypertension Systolic hypertension White coat hypertension Hypotension Orthostatic hypotension v t e Phakomatosis Angiomatosis Sturge–Weber syndrome Von Hippel–Lindau disease Hamartoma Tuberous sclerosis Hypothalamic hamartoma ( Pallister–Hall syndrome ) Multiple hamartoma syndrome Proteus syndrome Cowden syndrome Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Neurofibromatosis Type I Type II Other Abdallat–Davis–Farrage syndrome Ataxia telangiectasia Incontinentia pigmenti Peutz–Jeghers syndrome Encephalocraniocutaneous lipomatosis This Dermal and subcutaneous growths article is a stub .
    CD1A, PIK3CA, TSC2, NHLRC2
  • Marinesco–sjögren Syndrome Wikipedia
    Marinesco–Sjögren syndrome Specialty Neurology , medical genetics Marinesco–Sjögren syndrome ( MSS ), sometimes spelled Marinescu–Sjögren syndrome , is a rare autosomal recessive disorder. ... It can be associated with mutations of the SIL1 gene , [2] [3] and a mutation can be found in about 50% of cases Differential diagnosis [ edit ] DDx includes Congenital Cataracts Facial Dysmorphism Neuropathy (CCFDN), Marinesco–Sjögren like syndrome with chylomicronemia, carbohydrate deficient glycoprotein syndromes, Lowe syndrome , and mitochondrial disease . ... "Mutations in SIL1 cause Marinesco–Sjögren syndrome, a cerebellar ataxia with cataract and myopathy". ... "The gene disrupted in Marinesco–Sjögren syndrome encodes SIL1, an HSPA5 cochaperone". ... External links [ edit ] mss at NIH / UW GeneTests GeneReview/NIH/UW entry on Marinesco–Sjögren Syndrome Classification D OMIM : 248800 MeSH : D013132 DiseasesDB : 31430 SNOMED CT : 80734006 External resources GeneReviews : Marinesco–Sjögren Syndrome Orphanet : 559 v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    SIL1, INPP5K, MLH1, BRAF, MSH2, KRAS, TP53, APC, CTNNB1, CD274, MGMT, VEGFA, CDKN2A, KRT20, FRTS1, HSPA5, MRC1, MSH6, IFNG, FGF2, HSPA4, TGFBR2, NFIX, POLE, PIK3CA, CTLA4, CARD11, EIF2AK3, C17orf97, PMS2, RAMP2, PROM1, TIMP2, TIMP3, MLH3, TYMS, VCAM1, PRDM2, MBD4, SULF1, PTGES, CTDP1, PHB2, RAB32, DCTN6, ZNRD2, IFT140, APTX, CNOT7, RERG, H3P23, TMED7-TICAM2, MIR20B, MIR17HG, MIR34B, MIR126, NDUFS7, TICAM2, TIGIT, ASXL1, NAV3, PHF6, TMED7, TCF7L1, SLCO5A1, PDCD1LG2, PPP1R2C, MTUS1, COQ8A, RCC2, NLRP2, RNF43, TET2, WWOX, TIMP1, ACVR2A, TCF3, IDH2, HRAS, GATA3, FRZB, FASN, EPHB2, EGFR, DUSP4, DPYD, DCC, CYLD, CTNND2, CSNK2A1, CSF1R, MAP3K8, COL11A2, CEBPA, CEACAM5, CD40LG, CD86, MS4A1, CD14, CD8A, RUNX3, BAX, ALK, HTC2, IFI27, SFRP4, IL1B, SFRP1, CXCL12, REG1A, PTGS2, PTEN, PSMD9, DNAJC3, PARP1, PMS1, PML, PITX2, PECAM1, PCNA, PAX5, NBN, MYC, MUC5AC, MUC2, MTHFR, MMP3, MET, MARCKS, JAK3, IL17A, IL6, H3P10
    • Marinesco-Sjögren Syndrome GeneReviews
      Genetic counseling. Marinesco-Sjögren syndrome (MSS) is inherited in an autosomal recessive manner. ... Diagnosis Suggestive Findings Marinesco-Sjögren syndrome (MSS) should be suspected in individuals with the following clinical findings: Cerebellar ataxia with cerebellar atrophy, dysarthria, and nystagmus MRI. ... Clinical Characteristics Clinical Description Infants with Marinesco-Sjögren syndrome (MSS) are born after uncomplicated pregnancies. ... Nomenclature Previously used terms for Marinesco-Sjögren syndrome: Garland-Moorhouse syndrome Marinesco-Garland syndrome Hereditary oligophrenic cerebello-lental degeneration Individuals first described as having Marinesco-Sjögren-like syndrome (also called ataxia-juvenile cataract-myopathy-intellectual disability [OMIM 248810]) were later found to have classic MSS with SIL1 pathogenic variants, resulting in discontinuation of this OMIM entry. ... Differential Diagnosis In individuals with atypical features of Marinesco-Sjögren syndrome (MSS), the differential diagnostic possibilities that should be considered are listed in Table 2.
    • Marinesco-Sjögren Syndrome MedlinePlus
      Marinesco-Sjögren syndrome is a condition that has a variety of signs and symptoms affecting many tissues. People with Marinesco-Sjögren syndrome have clouding of the lens of the eyes (cataracts ) that usually develops soon after birth or in early childhood. ... Most people with Marinesco-Sjögren syndrome have mild to moderate intellectual disability. ... As a result, puberty is either delayed or absent. Frequency Marinesco-Sjögren syndrome appears to be a rare condition. ... This accumulation likely damages and destroys cells in many different tissues, leading to ataxia, myopathy, and the other features of Marinesco-Sjögren syndrome. Approximately one-third of people with Marinesco-Sjögren syndrome do not have identified mutations in the SIL1 gene.
    • Marinesco-Sjögren Syndrome Orphanet
      Marinesco-Sjögren syndrome (MSS) belongs to the group of autosomal recessive cerebellar ataxias. ... Etiology It has been suggested that the MSS with myoglobinuria and congenital cataracts-facial dysmorphism-neuropathy (CCFDN) syndromes are genetically identical as they both map to chromosome 18qter.
    • Marinesco-Sjogren Syndrome OMIM
      A number sign (#) is used with this entry because Marinesco-Sjogren syndrome (MSS) is caused by homozygous or compound heterozygous mutation in the SIL1 gene (608005) on chromosome 5q31. ... Skre and Berg (1977) observed 10 persons with Marinesco-Sjogren syndrome in 2 kindreds, 9 of whom also had hypogonadism. ... In 4 members of 2 Finnish families, Herva et al. (1987) described a cerebrooculomuscular syndrome that the authors considered to be distinct from MSS. ... Senderek et al. (2005) defined Marinesco-Sjogren syndrome as a disease of endoplasmic reticulum dysfunction and suggested that this organelle has a role in multisystem disorders. ... History Superneau et al. (1985) pointed to a description of this syndrome reported in the Hungarian medical literature in 1904.
  • Zap70 Deficiency Wikipedia
    Further reading [ edit ] GeneReviews/NCBI/NIH/UW entry on ZAP70-Related Severe Combined Immunodeficiency ZAP70 deficiency; Selective T-cell defect; Zeta-associated-protein 70 deficiency at NIH 's Office of Rare Diseases External links [ edit ] Classification D ICD - 10 : D81.8 OMIM : 176947 External resources Orphanet : 911 v t e Lymphoid and complement disorders causing immunodeficiency Primary Antibody / humoral ( B ) Hypogammaglobulinemia X-linked agammaglobulinemia Transient hypogammaglobulinemia of infancy Dysgammaglobulinemia IgA deficiency IgG deficiency IgM deficiency Hyper IgM syndrome ( 1 2 3 4 5 ) Wiskott–Aldrich syndrome Hyper-IgE syndrome Other Common variable immunodeficiency ICF syndrome T cell deficiency ( T ) thymic hypoplasia : hypoparathyroid ( Di George's syndrome ) euparathyroid ( Nezelof syndrome Ataxia–telangiectasia ) peripheral: Purine nucleoside phosphorylase deficiency Hyper IgM syndrome ( 1 ) Severe combined (B+T) x-linked: X-SCID autosomal: Adenosine deaminase deficiency Omenn syndrome ZAP70 deficiency Bare lymphocyte syndrome Acquired HIV/AIDS Leukopenia : Lymphocytopenia Idiopathic CD4+ lymphocytopenia Complement deficiency C1-inhibitor ( Angioedema / Hereditary angioedema ) Complement 2 deficiency / Complement 4 deficiency MBL deficiency Properdin deficiency Complement 3 deficiency Terminal complement pathway deficiency Paroxysmal nocturnal hemoglobinuria Complement receptor deficiency v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    ZAP70, CYBB, PNP, NCF1
    • Immunodeficiency 48 OMIM
      A number sign (#) is used with this entry because immunodeficiency-48 (IMD48), characterized by selective T-cell defect (STCD), is caused by homozygous or compound heterozygous mutation in the ZAP70 gene (176947) on chromosome 2q11. Clinical Features Roifman et al. (1989) described a female infant with a novel type of human immunodeficiency characterized by a selective T-cell defect. Peripheral circulating T cells from these patients exclusively expressed CD4, CD3, and T-cell receptor-alpha/beta, but not CD8 molecules on their surface. The inability to produce peripheral CD8 single-positive cells was traced to an intrathymic developmental defect. Whereas CD4(+)/CD8(+)-positive cells were present in the thymic cortex of these patients, only CD4, not CD8, single-positive cells could be detected in the thymic medulla, suggesting a selective block of positive selection of CD8+ cells.
    • Zap70-Related Severe Combined Immunodeficiency MedlinePlus
      ZAP70 -related severe combined immunodeficiency (SCID) is an inherited disorder that damages the immune system. ZAP70 -related SCID is one of several forms of severe combined immunodeficiency, a group of disorders with several genetic causes. Children with SCID lack virtually all immune protection from bacteria, viruses, and fungi. They are prone to repeated and persistent infections that can be very serious or life-threatening. Often the organisms that cause infection in people with this disorder are described as opportunistic because they ordinarily do not cause illness in healthy people.
    • Combined Immunodeficiency Due To Zap70 Deficiency Orphanet
      A very rare, severe, genetic, combined immunodeficiency disorder characterized by lymphocytosis, decreased peripheral CD8+ T-cells, and presence of normal circulating CD4+ T-cells, leading to immune dysfunction.
  • Polycystic Liver Disease Wikipedia
    External links [ edit ] Classification D ICD - 10 : Q44.6 OMIM : 174050 MeSH : C536330 DiseasesDB : 33340 v t e Congenital malformations and deformations of digestive system Upper GI tract Tongue , mouth and pharynx Cleft lip and palate Van der Woude syndrome tongue Ankyloglossia Macroglossia Hypoglossia Esophagus EA/TEF Esophageal atresia: types A, B, C, and D Tracheoesophageal fistula: types B, C, D and E esophageal rings Esophageal web (upper) Schatzki ring (lower) Stomach Pyloric stenosis Hiatus hernia Lower GI tract Intestines Intestinal atresia Duodenal atresia Meckel's diverticulum Hirschsprung's disease Intestinal malrotation Dolichocolon Enteric duplication cyst Rectum / anal canal Imperforate anus Rectovestibular fistula Persistent cloaca Rectal atresia Accessory Pancreas Annular pancreas Accessory pancreas Johanson–Blizzard syndrome Pancreas divisum Bile duct Choledochal cysts Caroli disease Biliary atresia Liver Alagille syndrome Polycystic liver disease v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    SEC63, PRKCSH, LRP5, ALG8, ALG9, PKD2, PKHD1, PKD1, GANAB, TMEM216, MKS1, WDPCP, TMEM231, CEP55, RPGRIP1L, RPGRIP1, B9D1, TCTN2, CSPP1, CEP290, B9D2, TMEM107, FBN1, TMEM67, CC2D2A, SST, GPBAR1, SIL1, NXN, CDC25A, SEC61B, HDAC6, FGF23, RASGRF1, PRKD1, GPLD1, CDC25C, ADCY5
    • Polycystic Liver Disease 2 With Or Without Kidney Cysts OMIM
      A number sign (#) is used with this entry because of evidence that polycystic liver disease-2 with or without kidney cysts (PCLD2) is caused by heterozygous mutation in the SEC63 gene (608648) on chromosome 6q21. Description PCLD2 is an autosomal dominant disease characterized by the presence of multiple liver cysts resulting from structural changes in the biliary tree during development. Abnormal biliary structures may be present early in life, but they usually remain asymptomatic until cyst growth initiates during adulthood. In advanced stages, patients may develop massively enlarged livers, which cause a spectrum of clinical features and complications. Genetic studies suggest that an accumulation of somatic hits in cyst epithelium determines the rate of cyst formation.
    • Polycystic Liver Disease 1 With Or Without Kidney Cysts OMIM
      A number sign (#) is used with this entry because of evidence that polycystic liver disease-1 with or without kidney cysts (PCLD1) is caused by heterozygous mutation in the PRKCSH gene (177060) on chromosome 19p13. Description Polycystic liver disease-1 is an autosomal dominant condition characterized by the presence of multiple liver cysts of biliary epithelial origin. Although the clinical presentation and histologic features of polycystic liver disease in the presence or absence of autosomal dominant polycystic kidney disease (see, e.g., PKD1, 173900) are indistinguishable, PCLD1 is a genetically distinct form of isolated polycystic liver disease (summary by Reynolds et al., 2000). A subset of patients (28-35%) may develop kidney cysts that are usually incidental findings and do not result in clinically significant renal disease (review by Cnossen and Drenth, 2014). Genetic Heterogeneity of Polycystic Liver Disease See also PCLD2 (617004), caused by mutation in the SEC63 gene (608648) on chromosome 6q21; PCLD3 (617874), caused by mutation in the ALG8 gene (608103) on chromosome 11p; and PCLD4 (617875), causes by mutation in the LRP5 gene (603506) on chromosome 11q13.
    • Isolated Polycystic Liver Disease Orphanet
      Isolated polycystic liver disease (PCLD) is a genetic disorder characterized by the appearance of numerous cysts spread throughout the liver and that in most cases is described as autosomal dominant polycystic liver disease (ADPCLD). Epidemiology The prevalence of ADPCLD is 1/100, 000. Clinical description Women are predominantly affected and have a larger number of cysts than affected males. Cysts are undetectable early in life and usually appear after the age of 40 years. Their number and size increases with age. Symptoms depend on the mass (compression effect) and can include abdominal distension, gastro-esophageal reflux, early satiety, dyspnea, decreased mobility and back pain due to hepatomegaly. Some patients are asymptomatic. Other complications (intracystic hemorrhage or infection, torsion or rupture of cysts) can cause acute abdominal pain.
    • Polycystic Liver Disease GARD
      Polycystic liver disease is an inherited condition characterized by many cysts of various sizes scattered throughout the liver . Abdominal discomfort from swelling of the liver may occur; however, most affected individuals do not have any symptoms. In some cases, polycystic liver disease appears to occur randomly, with no apparent cause. Most cases are inherited in an autosomal dominant fashion. Sometimes, cysts are found in the liver in association with the presence of autosomal dominant polycystic kidney disease (AD-PKD) . In fact, about half of the people who have AD-PKD experience liver cysts.
  • Peutz–jeghers Syndrome Wikipedia
    Peutz-Jeghers syndrome Micrograph of Peutz-Jeghers type colonic polyp . ... This report suggested that follow up of sinus polyps in this syndrome may be indicated. [12] Monitoring [ edit ] Barium enema radiograph showing multiple polyps (mostly pedunculated) and at least one large mass at the hepatic flexure coated with contrast in a patient with Peutz–Jeghers syndrome. ... Cancer Syndromes . ^ a b McGarrity, Thomas J; Amos, Christopher I; Frazier, Marsha L; Wei, Chongjuan (July 25, 2013). ... PMID 20301443 . ^ Riegert-Johnson D, Gleeson FC, Westra W, et al. Peutz-Jeghers Syndrome. 2008 Jul 18 [Updated 2008 Aug 9]. ... GeneReviews/NCBI/NIH/UW entry on Peutz-Jeghers syndrome Peutz-Jeghers syndrome – Genetics Home Reference v t e Phakomatosis Angiomatosis Sturge–Weber syndrome Von Hippel–Lindau disease Hamartoma Tuberous sclerosis Hypothalamic hamartoma ( Pallister–Hall syndrome ) Multiple hamartoma syndrome Proteus syndrome Cowden syndrome Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Neurofibromatosis Type I Type II Other Abdallat–Davis–Farrage syndrome Ataxia telangiectasia Incontinentia pigmenti Peutz–Jeghers syndrome Encephalocraniocutaneous lipomatosis v t e Digestive system neoplasia GI tract Upper Esophagus Squamous cell carcinoma Adenocarcinoma Stomach Gastric carcinoma Signet ring cell carcinoma Gastric lymphoma MALT lymphoma Linitis plastica Lower Small intestine Duodenal cancer Adenocarcinoma Appendix Carcinoid Pseudomyxoma peritonei Colon/rectum Colorectal polyp : adenoma , hyperplastic , juvenile , sessile serrated adenoma , traditional serrated adenoma , Peutz–Jeghers Cronkhite–Canada Polyposis syndromes: Juvenile MUTYH-associated Familial adenomatous / Gardner's Polymerase proofreading-associated Serrated polyposis Neoplasm: Adenocarcinoma Familial adenomatous polyposis Hereditary nonpolyposis colorectal cancer Anus Squamous cell carcinoma Upper and/or lower Gastrointestinal stromal tumor Krukenberg tumor (metastatic) Accessory Liver malignant : Hepatocellular carcinoma Fibrolamellar Hepatoblastoma benign : Hepatocellular adenoma Cavernous hemangioma hyperplasia : Focal nodular hyperplasia Nodular regenerative hyperplasia Biliary tract bile duct : Cholangiocarcinoma Klatskin tumor gallbladder : Gallbladder cancer Pancreas exocrine pancreas : Adenocarcinoma Pancreatic ductal carcinoma cystic neoplasms : Serous microcystic adenoma Intraductal papillary mucinous neoplasm Mucinous cystic neoplasm Solid pseudopapillary neoplasm Pancreatoblastoma Peritoneum Primary peritoneal carcinoma Peritoneal mesothelioma Desmoplastic small round cell tumor v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    STK11, DEFA5, TP53, PTEN, CTNNB1, PTGS2, CYP19A1, COX2, H3P10, CDKN2A, MTCO2P12, TSC2, PPFIA1, KRAS, LIAS, SMARCA4, CENPJ, STK11IP, PRKAR1A, MYH11, MEN1, SMAD4, APC, CYP2B6, BRCA2, MTOR, FNDC3A, VHL, WNT5A, NKX2-5, IFITM1, NR1I2, NEK6, CDX2, CDC37, CHEK2, INHA, TSC1, TESC, BUB1, MARK4, SLC52A2, SLC25A21, STRADA, PWAR1, BRCA1, CAB39, ARID3A, IL11, APRT, SMAD2, HSP90AA1, MARK1, MSH6, MFAP1, GNAS, MUTYH, ODC1, PRKAA1, PRKAB1, EGFR, FAP, F2R, ESR1, PTPRH, REN, MAP2K4, SLC12A3, ENG, STAT3, PRKAA2
    • Peutz-Jeghers Syndrome GeneReviews
      Diagnosis/testing. The diagnosis of Peutz-Jeghers syndrome is based on clinical findings. ... PTEN hamartoma tumor syndrome (PHTS), an autosomal dominant cancer syndrome caused by mutation of PTEN , includes Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN -related Proteus syndrome, and a Proteus-like syndrome. The extraintestinal manifestations are more pronounced than intestinal polyposis. The features of Cowden syndrome that distinguish it from PJS include facial trichilemmomas, mucosal papillomas, acral keratoses, macrocephaly, and tumors of the thyroid, breast, and endometrium. ... Proteus-like syndrome is undefined but refers to individuals with significant clinical features of Proteus syndrome who do not meet the diagnostic criteria for Proteus syndrome. ... = anecdotal association; CC = Carney complex; CHRPE = congenital hypertrophy of the retinal pigment epithelium; CS = Cowden syndrome; FAP = familial adenomatous polyposis; HNPCC = hereditary non-polyposis colorectal cancer; JPS = juvenile polyposis syndrome The differential diagnosis of oral pigmented lesions includes the following: The Laugier-Hunziker syndrome is characterized by the presence of perioral, digit and nailbed lentiginosis (small, well-demarcated; dark-brown to blue-black in color).
    • Peutz-Jeghers Syndrome Orphanet
      A genetic intestinal polyposis syndrome characterized by development of characteristic hamartomatous polyps throughout the gastrointestinal (GI) tract, and by mucocutaneous pigmentation. This disorder carries a considerably increased risk of GI and extra-GI malignancies. Epidemiology Peutz-Jeghers syndrome (PJS) prevalence estimates range from 1/25,000 to 1/300,000 births. ... Differential diagnosis Differential diagnoses include juvenile polyposis syndrome, hereditary mixed polyposis syndrome, the PTEN hamartoma tumor syndromes, and Carney complex. Antenatal diagnosis Prenatal diagnosis for increased risk pregnancies is available provided that the disease-causing mutation has been identified in the family. Genetic counseling The syndrome is inherited in an autosomal dominant manner.
    • Peutz-Jeghers Syndrome GARD
      Peutz-Jeghers syndrome (PJS) is an inherited condition that is associated with an increased risk of growths along the lining of the gastrointestinal tract (called hamartomatous polyps) and certain types of cancer.
    • Peutz-Jeghers Syndrome OMIM
      Metastases from a malignant polyp in Peutz-Jeghers syndrome was reported by Williams and Knudsen (1965). ... Brigg et al. (1976) observed a case of presumed Peutz-Jeghers syndrome without spots or positive family history. ... Three other reported male patients with Peutz-Jeghers syndrome and gonadal tumors had presented with gynecomastia between birth and 6 years of age. ... Another member developed short bowel syndrome. In the follow-up of 72 patients with PJS in the St. ... In a patient with Peutz-Jeghers syndrome, Markie et al. (1996) demonstrated a pericentric inversion in chromosome 6.
    • Peutz-Jeghers Syndrome MedlinePlus
      Children with Peutz-Jeghers syndrome often develop small, dark-colored spots on the lips , around and inside the mouth , near the eyes and nostrils, and around the anus. ... In addition, most people with Peutz-Jeghers syndrome develop multiple polyps in the stomach and intestines during childhood or adolescence. ... The resulting uncontrolled cell growth leads to the formation of noncancerous polyps and cancerous tumors in people with Peutz-Jeghers syndrome. A small percentage of people with Peutz-Jeghers syndrome do not have mutations in the STK11 gene. ... Learn more about the gene associated with Peutz-Jeghers syndrome STK11 Inheritance Pattern Peutz-Jeghers syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to increase the risk of developing noncancerous polyps and cancerous tumors. ... The remaining cases occur in people with no history of Peutz-Jeghers syndrome in their family. These cases appear to result from new (de novo) mutations in the STK11 gene.
  • Cardiofaciocutaneous Syndrome Wikipedia
    Genes that are mutated in all three of these syndromes encode proteins that function in the MAP kinase pathway. Mutations that cause CFC are found in the KRAS , BRAF , MEK1 and MEK2 genes. Costello syndrome is caused by mutations in HRAS . Mutations that cause Noonan syndrome have been found in PTPN11 and SOS1 . The relative severity of CFC when compared to Noonan syndrome may reflect the position in the biochemical pathway each gene occupies. ... External links [ edit ] Classification D ICD - 10 : Q87.8 OMIM : 115150 MeSH : C535579 DiseasesDB : 30111 CFC Syndrome at Genetics Home Reference GeneReview/UW/NIH entry on CFC v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    BRAF, MAP2K1, KRAS, MAP2K2, HRAS, PTPN11, NRAS, RAF1, SOS1, SHOC2, RRAS, A2ML1, MRAS, LZTR1, SOS2, RASA2, RIT1, RASA1, PPP1CB, EPHB2, MAPK1, MAP2K7, SGSM3, ZHX2, YWHAZ, CFC1, NPPC, KANSL1
    • Cardiofaciocutaneous Syndrome 1 OMIM
      Roberts et al. (2006) provided a detailed review of CFC syndrome, including a discussion of the phenotypic overlap of CFC syndrome with Noonan syndrome (NS1; 163950) and Costello syndrome (218040). ... They described mother and daughter who had features consistent with the CFC syndrome but had other features which have been reported in the Noonan syndrome but not in the CFC syndrome, namely, hemorrhagic diathesis and ocular abnormalities. ... Leichtman (1996) described a family suggesting that CFC syndrome is a variable expression of Noonan syndrome. ... Molecular Genetics The phenotypic overlap among CFC syndrome, Noonan syndrome, and Costello syndrome, and the finding of causative mutations for the latter syndromes in the PTPN11 and HRAS (190020) genes, respectively, suggested to Niihori et al. (2006) that the action of the RAS-MAPK pathway is the common underlying mechanism of Noonan syndrome and Costello syndrome and, hence, possibly of CFC syndrome. ... Gripp et al. (2007) reported 13 unrelated patients ages 0 to 8 years with a clinical diagnosis of Costello syndrome (218040), Costello-like syndrome, or thought to have either CFC syndrome or Costello syndrome who were negative for mutations in the HRAS gene.
    • Cardiofaciocutaneous Syndrome GARD
      Cardiofaciocutaneous (CFC) syndrome is a disorder that affects many parts of the body, particularly the heart, face, skin, and hair. People with this condition also have developmental delay and intellectual disability, usually ranging from moderate to severe. The signs and symptoms of CFC syndrome overlap significantly with those of two other conditions, Costello syndrome and Noonan syndrome . These syndromes belong to a group of related conditions called the RASopathies , which are distinguished by their genetic causes and specific pattern of features. It can sometimes be hard to tell these conditions apart in infancy. CFC syndrome is usually caused by a mutation in the BRAF gene, but can also be due to a mutation in the MAP2K1 , MAP2K2 or KRAS g ene.
    • Cardiofaciocutaneous Syndrome GeneReviews
      The face is broader and longer, overall more coarse, than in Noonan syndrome (a clinically similar disorder often confused with CFC syndrome), but usually not as coarse as typically seen in Costello syndrome. ... At present, no longitudinal or natural history studies have been done for CFC syndrome. However, CFC syndrome does have an evolving phenotype. ... By late adolescence to early adulthood, the craniofacial appearance becomes less like that seen in Noonan syndrome. Neoplasias (e.g., benign papillomas or malignancies observed in the other RASopathies including Costello syndrome, Noonan syndrome, or neurofibromatosis type 1) have not been reported in CFC syndrome. ... However, with closer clinical examination, the clinical diagnosis was consistent with CFC syndrome. Costello syndrome and cardiofaciocutaneous (CFC) syndrome have many overlapping phenotypic features, underscoring the difficulty in making a clinical diagnosis based on phenotypic features alone. Individuals with BRAF pathogenic variants have the diagnosis of CFC syndrome, even if they have features that may be present in Costello syndrome or have phenotypic overlap with Noonan syndrome (see following).
    • Cardiofaciocutaneous Syndrome MedlinePlus
      Cardiofaciocutaneous syndrome is also characterized by distinctive facial features. ... The signs and symptoms of cardiofaciocutaneous syndrome overlap significantly with those of two other genetic conditions, Costello syndrome and Noonan syndrome. ... Frequency Cardiofaciocutaneous syndrome is a very rare condition whose incidence is unknown. ... In these cases, affected individuals may actually have Costello syndrome or Noonan syndrome, which are also caused by mutations in genes involved in RAS/MAPK signaling. ... The group of related conditions that includes cardiofaciocutaneous syndrome, Costello syndrome, and Noonan syndrome is often called the RASopathies.
    • Cardiofaciocutaneous Syndrome 3 OMIM
      A number sign (#) is used with this entry because of evidence that cardiofaciocutaneous syndrome-3 (CFC3) is caused by heterozygous mutation in the MAP2K1 gene (176872) on chromosome 15q22. For a general phenotypic description and a discussion of genetic heterogeneity of cardiofaciocutaneous syndrome, see CFC1 (115150). Description Cardiofaciocutaneous syndrome (CFC) is a complex developmental disorder involving characteristic craniofacial features, cardiac anomalies, hair and skin abnormalities, postnatal growth deficiency, hypotonia, and developmental delay.
    • Cardiofaciocutaneous Syndrome 2 OMIM
      A number sign (#) is used with this entry because this form of cardiofaciocutaneous syndrome (CFC2) is caused by heterozygous mutation in the KRAS gene (190070) on chromosome 12p12.1. For a general phenotypic description and a discussion of genetic heterogeneity of cardiofaciocutaneous syndrome, see CFC1 (115150). Description Cardiofaciocutaneous (CFC) syndrome is a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects, and mental retardation (summary by Niihori et al., 2006). ... Clinical Features Wieczorek et al. (1997) described a female patient (patient 2) with cardiofaciocutaneous syndrome. She was noted to be hypotonic in the first few weeks of life, and early development was complicated by hypertrophic obstructive cardiomyopathy, atrial septal defect, and pulmonic stenosis. ... Wieczorek et al. (1997) also described 2 other patients, provided a detailed review of previously reported cases, and discussed the differences from Noonan (see 163950) and Costello (218040) syndromes. Stark et al. (2012) reported 3 patients from 2 families with CFC2. ... The proband of the second family, who had an unaffected dizygotic twin, had a high birth weight, macrocephaly, and abnormal craniofacial features, including proptosis, hypertelorism, downslanting palpebral fissures, low-set ears, and short neck, suggestive of Noonan syndrome. Reexamination at age 3.5 years showed coarser facial features more consistent with CFC.
    • Cardiofaciocutaneous Syndrome 4 OMIM
      A number sign (#) is used with this entry because of evidence that cardiofaciocutaneous syndrome-4 (CFC4) is caused by heterozygous mutation in the MAPK2K2 gene (601263) on chromosome 19p13. For a general phenotypic description and a discussion of genetic heterogeneity of cardiofaciocutaneous syndrome, see CFC1 (115150). Description Cardiofaciocutaneous (CFC) syndrome is a multiple congenital anomaly disorder in which individuals have characteristic craniofacial features, cardiac defects, ectodermal anomalies, gastrointestinal dysfunction, and neurocognitive delay (summary by Rauen et al., 2010). ... Molecular Genetics Cardiofaciocutaneous syndrome most commonly occurs as a sporadic disorder, resulting from de novo heterozygous mutations in any of the 4 genes associated with the disorder.
    • Cardiofaciocutaneous Syndrome Orphanet
      A rare, multiple congenital anomalies syndrome characterized by craniofacial dysmorphology, congenital heart disease, dermatological abnormalities (most commonly hyperkeratotic skin and sparse, curly hair), neurological manifestations (hypotonia, seizures), failure to thrive and intellectual disability. ... Clinical description Cardiofaciocutaneous (CFC) syndrome displays wide phenotypic variability. ... In 50% of cases, seizures can also be present. Etiology CFC syndrome is considered a RASopathy and is due to mutations in one of the 4 genes: BRAF (7q34) (in 75% of CFC cases), MAP2K1 (15q22.1-q22.33), MAP2K2 (19p13.3), and KRAS (12p12.1), which encode proteins of the sarcoma/mitrogen-activated protein kinase (RAS/MAPK) signaling pathway. ... Differential diagnosis Differential diagnoses include Costello Syndrome (CS) and Noonan Syndrome, which have overlapping phenotypes with CFC syndrome. CFC syndrome, unlike CS, does not appear to have an increased risk of malignancies.
  • Parietal Foramina 1 OMIM
    Genetic Heterogeneity of Parietal Foramina See also PFM2 (609597) and the 11p11.2 deletion syndrome (601224), in which parietal foramina are caused by haploinsufficiency of the ALX4 gene (605420) on chromosome 11p. ... Clinical Features Goldsmith (1922) called this condition 'Catlin marks' because he observed 16 instances in 5 generations of the Catlin family. This, like Hartnup disease, Cowden syndrome, Lutheran trait, and Hageman factor, is one of the few examples of hereditary traits named for the family in which it was first observed. ... Chrzanowska et al. (1998) reported a patient with a 'new' branchial syndrome that included the features of parietal foramina; Rauch et al. (1998) considered the patient to represent a case of the FG syndrome (305450).
    ALX4, MSX2, EXT2, ALX3, TWIST1, CREBBP, EP300, FGFR2, PHF21A, RPS19, ALX1, SCN4A, CACNA1S, TNF, UGT8, USP14, PRDM5, IL6, CAT, QTRT1
    • Enlarged Parietal Foramina GeneReviews
      Methods used may include quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications. 6. Excluding syndromic cases, sequence-level changes comprise the majority of pathogenic variants [Wilkie et al 2000; Wuyts et al 2000a; Wuyts et al 2000b; Mavrogiannis et al 2001; Spruijt et al 2005; Ghassibé et al 2006; Mavrogiannis et al 2006; Altunoglu et al 2014; Farwell et al 2015; Meng et al 2017; Lee et al 2018; T Lester & H Lord, unpublished data]. 7. ... Additionally, isolated enlarged parietal foramina need to be distinguished from unequivocal syndromic associations including those described in Table 4. Table 4. Autosomal Dominant Syndromes with Enlarged Parietal Foramina to Consider in the Differential Diagnosis of Isolated Enlarged Parietal Foramina View in own window Disorder Gene(s) / Genetic Mechanism Clinical Features Potocki-Shaffer syndrome (OMIM 601224) Proximal 11p deletion See Genetically Related Disorders ALX4 -related frontonasal dysplasia (OMIM 613451) ALX4 See Genetically Related Disorders MSX2 -related cleidocranial dysplasia (OMIM 168550) MSX2 See Genetically Related Disorders Saethre-Chotzen syndrome TWIST1 Craniosynostosis syndrome characterized by coronal synostosis, facial asymmetry, ptosis, & distinctive appearance of the ear Syndactyly of digits 2 & 3 of the hand variably present Enlarged parietal foramina are a less common manifestation. Acromelic frontonasal dysostosis (OMIM 603671) ZSWIM6 Severe frontonasal dysplasia & cranium bifidum / enlarged parietal foramina Preaxial polydactyly Cryptorchidism in males CDAGS syndrome (craniofacial dysplasia with genitourinary and skin abnormalities; OMIM 603116) may also be considered. Consensus features of this rare autosomal recessive syndrome are coronal synostosis, wide fontanelles and enlarged parietal foramina, hypoplasia of the clavicles, imperforate anus, and skin eruptions.
    • Parietal Foramina 2 OMIM
      Parietal foramina also occur as part of the Potocki-Shaffer syndrome (601224), a contiguous gene syndrome caused by a deletion on chromosome 11p11.2 that includes the ALX4 gene. ... Mapping Using FISH, Wu et al. (2000) found a heterozygous deletion of a region corresponding to a BAC clone containing ALX4 on chromosome 11p in 2 patients with the Potocki-Shaffer syndrome. The authors stated that the involvement of Alx4 in murine skull development (Qu et al., 1997), its bone-specific expression pattern, the finding that Alx4 is a dosage-sensitive gene in the mouse, and the localization of a human genomic clone containing ALX4 to 11p11.2, with hemizygosity in patients with deletion of 11p11.2 who have biparietal foramina, supported the contention that ALX4 is a candidate gene for PFM in the Potocki-Shaffer syndrome.
    • Parietal Foramina 3 OMIM
      Description Parietal foramina-3 is a nonsyndromic developmental defect characterized by symmetrical oval holes in the parietal bone (Chen et al., 2003). For a discussion of genetic heterogeneity of parietal foramina, see 168500. Clinical Features Chen et al. (2003) reported a large Chinese pedigree in which 15 individuals spanning 4 generations had typical features of nonsyndromic PFM. Inheritance The transmission pattern of parietal foramina in the family described by Chen et al. (2003) was consistent with autosomal dominant inheritance. Mapping By genomewide scanning in a Chinese family segregating PFM, Chen et al. (2003) identified a putative locus, termed PFM3, on chromosome 4q21-q23 (maximum 2-point lod score of 3.87 at marker D4S2961; maximum multipoint lod score of 6.17 between D4S2986 and D4S421).
    • Enlarged Parietal Foramina Orphanet
      EPF can also be accompanied by meningeal, cortical, and vascular malformations of the posterior fossa (that may predispose to epilepsy), and Duane retraction syndrome (see this term). Craniofacial anomalies including cleft palate, myelomeningocele and isolated encephalocele are rarely associated (see these terms). ... Differential diagnosis Differential diagnosis includes Potocki-Shaffer syndrome; distal monosomy 15q; cleidocranial dysplasia; acromelic frontonasal dysplasia; craniosynostosis-anal anomalies-porokeratosis; and frontonasal dysplasia with alopecia and genital anomaly (see these terms).
  • Griscelli Syndrome Type 2 Wikipedia
    Griscelli syndrome type 2 Other names Hypopigmentation-immunodeficiency with or without neurologic impairment syndrome This condition is inherited in an autosomal recessive manner Griscelli syndrome type 2 (also known as " partial albinism with immunodeficiency ") is a rare autosomal recessive syndrome characterized by variable cutenous albinism, silver colored metallic looking hair, frequent bacterial or viral infections, neutropenia , and thrombocytopenia . [1] : 866 Contents 1 Presentation 2 Genetics 3 Diagnosis 3.1 Differential diagnosis 4 Treatment 5 History 6 See also 7 References 8 External links Presentation [ edit ] All types of Griscelli syndrome have distinctive skin and hair coloring. ... Type 2 - unlike type 1 - is not associated with primary neurological disease but is associated with an uncontrolled T lymphocyte expansion and macrophage activation syndrome . It is often associated with the hemophagocytic syndrome . ... Diagnosis [ edit ] Differential diagnosis [ edit ] This includes Chediak-Higashi syndrome and Elejalde syndrome (neuroectodermal melanolysosomal disease). ... Am J Med 65:691-702 ^ Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, Wulffraat N, Bianchi D, Fischer A, Le Deist F, de Saint Basile G (2000) Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. ... You can help Wikipedia by expanding it . v t e v t e Pigmentation disorders / Dyschromia Hypo- / leucism Loss of melanocytes Vitiligo Quadrichrome vitiligo Vitiligo ponctué Syndromic Alezzandrini syndrome Vogt–Koyanagi–Harada syndrome Melanocyte development Piebaldism Waardenburg syndrome Tietz syndrome Loss of melanin / amelanism Albinism Oculocutaneous albinism Ocular albinism Melanosome transfer Hermansky–Pudlak syndrome Chédiak–Higashi syndrome Griscelli syndrome Elejalde syndrome Griscelli syndrome type 2 Griscelli syndrome type 3 Other Cross syndrome ABCD syndrome Albinism–deafness syndrome Idiopathic guttate hypomelanosis Phylloid hypomelanosis Progressive macular hypomelanosis Leukoderma w/o hypomelanosis Vasospastic macule Woronoff's ring Nevus anemicus Ungrouped Nevus depigmentosus Postinflammatory hypopigmentation Pityriasis alba Vagabond's leukomelanoderma Yemenite deaf-blind hypopigmentation syndrome Wende–Bauckus syndrome Hyper- Melanin / Melanosis / Melanism Reticulated Dermatopathia pigmentosa reticularis Pigmentatio reticularis faciei et colli Reticulate acropigmentation of Kitamura Reticular pigmented anomaly of the flexures Naegeli–Franceschetti–Jadassohn syndrome Dyskeratosis congenita X-linked reticulate pigmentary disorder Galli–Galli disease Revesz syndrome Diffuse/ circumscribed Lentigo / Lentiginosis : Lentigo simplex Liver spot Centrofacial lentiginosis Generalized lentiginosis Inherited patterned lentiginosis in black persons Ink spot lentigo Lentigo maligna Mucosal lentigines Partial unilateral lentiginosis PUVA lentigines Melasma Erythema dyschromicum perstans Lichen planus pigmentosus Café au lait spot Poikiloderma ( Poikiloderma of Civatte Poikiloderma vasculare atrophicans ) Riehl melanosis Linear Incontinentia pigmenti Scratch dermatitis Shiitake mushroom dermatitis Other/ ungrouped Acanthosis nigricans Freckle Familial progressive hyperpigmentation Pallister–Killian syndrome Periorbital hyperpigmentation Photoleukomelanodermatitis of Kobori Postinflammatory hyperpigmentation Transient neonatal pustular melanosis Other pigments Iron Hemochromatosis Iron metallic discoloration Pigmented purpuric dermatosis Schamberg disease Majocchi's disease Gougerot–Blum syndrome Doucas and Kapetanakis pigmented purpura / Eczematid-like purpura of Doucas and Kapetanakis Lichen aureus Angioma serpiginosum Hemosiderin hyperpigmentation Other metals Argyria Chrysiasis Arsenic poisoning Lead poisoning Titanium metallic discoloration Other Carotenosis Tar melanosis Dyschromia Dyschromatosis symmetrica hereditaria Dyschromatosis universalis hereditaria See also Skin color Skin whitening Tanning Sunless Tattoo removal Depigmentation v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    RAB27A, FHL3, GLUL, UNC13D
    • Griscelli Syndrome, Type 2 OMIM
      For a discussion of phenotypic and genetic heterogeneity of Griscelli syndrome, see Griscelli syndrome type 1 (GS1; 214450). ... In a review, Klein et al. (1994) stated that Griscelli syndrome can be distinguished from Chediak-Higashi syndrome by pathognomonic histologic features. ... In 8 Saudi Arabian kindreds, Harfi et al. (1992) described a disorder characterized by partial albinism with immunodeficiency and progressive demyelination of brain white matter, referred to as PAID syndrome. Although the authors originally considered this syndrome to be distinct from both Chediak-Higashi syndrome and Griscelli syndrome, de Saint Basile (2007) stated that 1 of the Saudi Arabian kindreds reported by Harfi et al. (1992) was found to have a mutation in the RAB27A gene. ... Aksu et al. (2003) noted that the presence of white matter disease and the absence of hemophagocytosis in their patient were unusual for a patient with mutation in the RAB27A gene, and extended the phenotypic spectrum of Griscelli syndrome. Diagnosis Durandy et al. (1993) successfully undertook the prenatal diagnosis of 2 hereditary syndromes associating albinism and immune defects: Chediak-Higashi syndrome and Griscelli syndrome. ... Menasche et al. (2002), Huizing et al. (2002), and Bahadoran et al. (2003, 2003) also suggested the identity of Elejalde syndrome, at least in some patients, and Griscelli syndrome type 1.
    • Griscelli Syndrome Type 2 GARD
      Griscelli syndrome type 2 (GS2) is a rare, inherited condition that affects the skin, hair, and immune system.
    • Griscelli Syndrome Type 2 Orphanet
      A rare subtype of Griscelli syndrome characterized by pigmentary dilution in skin and hair with irregular clumps of pigment in hair shafts resulting in silvery hair, in association with increased susceptibility to recurrent infections and immunological abnormalities, in particular impairment of T-cell and natural killer cytotoxic activity eventually leading to hemophagocytic lymphohistiocytosis. Patients may present neurological manifestations related to infiltration of the central nervous system in the context of the hemophagocytic syndrome. The disease is mostly fatal in the first decade of life.
  • Hereditary Breast–ovarian Cancer Syndrome Wikipedia
    Hereditary breast–ovarian cancer syndrome Other names HBOC Ovarian and breast cancer patients in a pedigree chart of a family Specialty Obstetrics and gynaecology , endocrinology , dermatology , oncology , medical genetics Hereditary breast–ovarian cancer syndromes ( HBOC ) are cancer syndromes that produce higher than normal levels of breast cancer , ovarian cancer and additional cancers in genetically related families (either one individual had both, or several individuals in the pedigree had one or the other disease). ... Mutations in BRCA1 are associated with a 39-46% risk of ovarian cancer and mutations in BRCA2 are associated with a 10-27% risk of ovarian cancer. [5] Other identified genes include: MLH1 , MSH2 , MSH6 , PMS2 : mutations in genes that lead to Lynch Syndrome put individuals at risk for ovarian cancer. [6] TP53 : Mutations cause Li-Fraumeni syndrome . It produces particularly high rates of breast cancer among younger women with mutated genes, and despite being rare, 4% of women with breast cancer under age 30 have a mutation in this gene. [4] PTEN : Mutations cause Cowden syndrome , which produces hamartomas (benign polyps) in the colon, skin growths, and other clinical signs , as well as an increased risk for many cancers. [4] CDH1 : Mutations are associated with lobular breast cancer and gastric cancer . [4] STK11 : Mutations produce Peutz–Jeghers syndrome . ... ISBN 978-1-4987-4428-7 . ^ "Hereditary Breast Ovarian Cancer Syndrome (BRCA1 / BRCA2)" . Stanford University . ... (July 2019). "New name for breast-cancer syndrome could help to save lives" . Nature . 571 (7763): 27–29.
    BRCA1, BRCA2, TP53, RAD51C, CHEK2, PALB2, RAD51D, BRIP1, MRE11, BARD1, NBN, PTEN, RAD50, RAD51, ATM, MLH1, ABRAXAS1, RAD51B, RPL21P4, C11orf65, MSH6, MSH2, PMS2, KRT88P, KRAS, PRSS1, BRCA3, MRC1, AR, WT1, SEM1, VHL, PARP1, RASSF7, ALYREF, HOXB13, RNU1-4, OLA1, HSD17B7, BCCIP, EMSY, DHRS11, SLC22A12, HSD17B13, MIR146A, S100A2, PMS1, RB1, FANCC, APRT, CDH1, CDK2, CDKN2A, COL11A2, CRYGD, DHX8, EPHA3, ERBB2, ERCC4, FANCA, FAP, RAD52, HRAS, HSD11B2, HSD17B1, IGFBP4, KIT, MFAP1, MSH3, NF2, NOTCH3, NRAS, APC, LOC111589215
    • Brca2 Hereditary Breast And Ovarian Cancer Syndrome GARD
      BRCA2 hereditary breast and ovarian cancer syndrome ( BRCA2 HBOC) is an inherited condition that is characterized by an increased risk for a variety of different cancers.
    • Breast-Ovarian Cancer, Familial, Susceptibility To, 4 OMIM
      A number sign (#) is used with this entry because of evidence that susceptibility to familial breast-ovarian cancer-4 (BROVCA4) results from heterozygous germline mutation in the RAD51D gene (602954) on chromosome 17q11. For a discussion of genetic heterogeneity of breast-ovarian cancer susceptibility, see BROVCA1 (604370). For general discussions of breast cancer and ovarian cancer, see 114480 and 167000, respectively. Clinical Features Loveday et al. (2011) identified 8 families with breast-ovarian cancer associated with mutation in the RAD51D gene. Pathology information was available for 4 ovarian cancers from RAD51D mutation carriers; 3 of the cancers were serous adenocarcinoma and 1 was an endometrioid cancer.
    • Breast-Ovarian Cancer, Familial, Susceptibility To, 2 OMIM
      A number sign (#) is used with this entry because susceptibility to familial breast-ovarian cancer-2 (BROVCA2) results from heterozygous germline mutations in the BRCA2 gene (600185) on chromosome 13q13. For a discussion of genetic heterogeneity of breast-ovarian cancer susceptibility, see BROVCA1 (604370). For general discussions of breast cancer and ovarian cancer, see 114480 and 167000, respectively. Clinical Features Wooster et al. (1994) reported a large family from Utah segregating early-onset breast cancer, ovarian cancer, and male breast cancer. Thorlacius et al. (1995) described a family with multiple cases of male breast cancer but no increase in female breast cancer.
    • Breast-Ovarian Cancer, Familial, Susceptibility To, 1 OMIM
      Liede et al. (1998) raised the question of the existence of hereditary site-specific ovarian cancer as a genetic entity distinct from hereditary breast-ovarian cancer syndrome. They identified a large Ashkenazi Jewish kindred with 8 cases of ovarian carcinoma and no cases of breast cancer. ... Liede et al. (1998) concluded that site-specific ovarian cancer families probably represent a variant of the breast-ovarian cancer syndrome, attributable to mutation in either BRCA1 or BRCA2. ... Lynch and Watson (1992) reported extension of the linkage work to 19 families, most of which showed the hereditary breast-ovarian cancer syndrome. In 70% of families, linkage to 17q was demonstrated. ... Molecular Genetics In affected members of 5 of 8 kindreds with hereditary breast-ovarian cancer syndrome, Miki et al. (1994) identified 5 different heterozygous pathogenic mutations in the BRCA1 gene (see, e.g., 113705.0035). ... The single family with a BRCA2 mutation had the breast-ovarian cancer syndrome. Seven distinct mutations were identified; 5 of these occurred in 2 or more families.
    • Hereditary Breast And Ovarian Cancer Syndrome Orphanet
      Breast cancer (BC) is the most common cancer in women, accounting for 25% of all new cases of cancer. Most BC cases are sporadic, while 5-10% are estimated to be due to an inherited predisposition. Epidemiology Prevalence of germline BRCA mutations has been estimated to be about 1:1,600 women in the general population. The lifetime risk of developing hereditary BC (HBC) and/or OC can reach 80%. Clinical description HBC is not associated with specific phenotypic features.
    • Brca1 Hereditary Breast And Ovarian Cancer Syndrome GARD
      BRCA1 hereditary breast and ovarian cancer syndrome ( BRCA1 HBOC) is an inherited condition that is characterized by an increased risk for a variety of different cancers.
    • Breast-Ovarian Cancer, Familial, Susceptibility To, 3 OMIM
      A number sign (#) is used with this entry because susceptibility to familial breast-ovarian cancer-3 (BROVCA3) results from heterozygous germline mutation in the RAD51C gene (602774) on chromosome 17q21-q24. For a discussion of genetic heterogeneity of breast-ovarian cancer susceptibility, see BROVCA1 (604370). For general discussions of breast cancer and ovarian cancer, see 114480 and 167000, respectively. Clinical Features Meindl et al. (2010) identified 6 unrelated German pedigrees with breast-ovarian cancer associated with heterozygous germline mutations in the RAD51C gene. Each family had at least 2 affected women. The mean age of onset was 53 years (range 33 to 78) for breast cancer and 60 years (range 50 to 81) for ovarian cancer.
  • Incontinentia Pigmenti Wikipedia
    Incontinentia pigmenti Other names Bloch–Siemens syndrome, Bloch–Sulzberger disease, Bloch–Sulzberger syndrome, nelanoblastosis cutis, nevus pigmentosus systematicus [1] This condition is inherited in an X-linked dominant manner. ... "A pregnancy following PGD for X-linked autosomal dominant Incontinentia Pigmenti (Bloch-Sulzberger syndrome): Case Report" . Human Reproduction . 15 (12): 2650–2. doi : 10.1093/humrep/15.12.2650 . ... External links [ edit ] GeneReview/NIH/UW entry on Incontinentia Pigmenti Classification D ICD - 10 : Q82.3 ICD - 9-CM : 757.33 OMIM : 308300 MeSH : D007184 DiseasesDB : 29600 External resources MedlinePlus : 001583 eMedicine : article/1114205 article/1176285 GeneReviews : Incontinentia pigmenti Orphanet : 464 v t e Congenital malformations and deformations of integument / skin disease Genodermatosis Congenital ichthyosis / erythrokeratodermia AD Ichthyosis vulgaris AR Congenital ichthyosiform erythroderma : Epidermolytic hyperkeratosis Lamellar ichthyosis Harlequin-type ichthyosis Netherton syndrome Zunich–Kaye syndrome Sjögren–Larsson syndrome XR X-linked ichthyosis Ungrouped Ichthyosis bullosa of Siemens Ichthyosis follicularis Ichthyosis prematurity syndrome Ichthyosis–sclerosing cholangitis syndrome Nonbullous congenital ichthyosiform erythroderma Ichthyosis linearis circumflexa Ichthyosis hystrix EB and related EBS EBS-K EBS-WC EBS-DM EBS-OG EBS-MD EBS-MP JEB JEB-H Mitis Generalized atrophic JEB-PA DEB DDEB RDEB related: Costello syndrome Kindler syndrome Laryngoonychocutaneous syndrome Skin fragility syndrome Ectodermal dysplasia Naegeli syndrome / Dermatopathia pigmentosa reticularis Hay–Wells syndrome Hypohidrotic ectodermal dysplasia Focal dermal hypoplasia Ellis–van Creveld syndrome Rapp–Hodgkin syndrome / Hay–Wells syndrome Elastic / Connective Ehlers–Danlos syndromes Cutis laxa ( Gerodermia osteodysplastica ) Popliteal pterygium syndrome Pseudoxanthoma elasticum Van der Woude syndrome Hyperkeratosis / keratinopathy PPK diffuse : Diffuse epidermolytic palmoplantar keratoderma Diffuse nonepidermolytic palmoplantar keratoderma Palmoplantar keratoderma of Sybert Meleda disease syndromic connexin Bart–Pumphrey syndrome Clouston's hidrotic ectodermal dysplasia Vohwinkel syndrome Corneodermatoosseous syndrome plakoglobin Naxos syndrome Scleroatrophic syndrome of Huriez Olmsted syndrome Cathepsin C Papillon–Lefèvre syndrome Haim–Munk syndrome Camisa disease focal : Focal palmoplantar keratoderma with oral mucosal hyperkeratosis Focal palmoplantar and gingival keratosis Howel–Evans syndrome Pachyonychia congenita Pachyonychia congenita type I Pachyonychia congenita type II Striate palmoplantar keratoderma Tyrosinemia type II punctate : Acrokeratoelastoidosis of Costa Focal acral hyperkeratosis Keratosis punctata palmaris et plantaris Keratosis punctata of the palmar creases Schöpf–Schulz–Passarge syndrome Porokeratosis plantaris discreta Spiny keratoderma ungrouped: Palmoplantar keratoderma and spastic paraplegia desmoplakin Carvajal syndrome connexin Erythrokeratodermia variabilis HID / KID Other Meleda disease Keratosis pilaris ATP2A2 Darier's disease Dyskeratosis congenita Lelis syndrome Dyskeratosis congenita Keratolytic winter erythema Keratosis follicularis spinulosa decalvans Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome Keratosis pilaris atrophicans faciei Keratosis pilaris Other cadherin EEM syndrome immune system Hereditary lymphedema Mastocytosis / Urticaria pigmentosa Hailey–Hailey see also Template:Congenital malformations and deformations of skin appendages , Template:Phakomatoses , Template:Pigmentation disorders , Template:DNA replication and repair-deficiency disorder Developmental anomalies Midline Dermoid cyst Encephalocele Nasal glioma PHACE association Sinus pericranii Nevus Capillary hemangioma Port-wine stain Nevus flammeus nuchae Other/ungrouped Aplasia cutis congenita Amniotic band syndrome Branchial cyst Cavernous venous malformation Accessory nail of the fifth toe Bronchogenic cyst Congenital cartilaginous rest of the neck Congenital hypertrophy of the lateral fold of the hallux Congenital lip pit Congenital malformations of the dermatoglyphs Congenital preauricular fistula Congenital smooth muscle hamartoma Cystic lymphatic malformation Median raphe cyst Melanotic neuroectodermal tumor of infancy Mongolian spot Nasolacrimal duct cyst Omphalomesenteric duct cyst Poland anomaly Rapidly involuting congenital hemangioma Rosenthal–Kloepfer syndrome Skin dimple Superficial lymphatic malformation Thyroglossal duct cyst Verrucous vascular malformation Birthmark v t e Phakomatosis Angiomatosis Sturge–Weber syndrome Von Hippel–Lindau disease Hamartoma Tuberous sclerosis Hypothalamic hamartoma ( Pallister–Hall syndrome ) Multiple hamartoma syndrome Proteus syndrome Cowden syndrome Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Neurofibromatosis Type I Type II Other Abdallat–Davis–Farrage syndrome Ataxia telangiectasia Incontinentia pigmenti Peutz–Jeghers syndrome Encephalocraniocutaneous lipomatosis v t e X-linked disorders X-linked recessive Immune Chronic granulomatous disease (CYBB) Wiskott–Aldrich syndrome X-linked severe combined immunodeficiency X-linked agammaglobulinemia Hyper-IgM syndrome type 1 IPEX X-linked lymphoproliferative disease Properdin deficiency Hematologic Haemophilia A Haemophilia B X-linked sideroblastic anemia Endocrine Androgen insensitivity syndrome / Spinal and bulbar muscular atrophy KAL1 Kallmann syndrome X-linked adrenal hypoplasia congenita Metabolic Amino acid : Ornithine transcarbamylase deficiency Oculocerebrorenal syndrome Dyslipidemia : Adrenoleukodystrophy Carbohydrate metabolism : Glucose-6-phosphate dehydrogenase deficiency Pyruvate dehydrogenase deficiency Danon disease/glycogen storage disease Type IIb Lipid storage disorder : Fabry's disease Mucopolysaccharidosis : Hunter syndrome Purine–pyrimidine metabolism : Lesch–Nyhan syndrome Mineral : Menkes disease / Occipital horn syndrome Nervous system X-linked intellectual disability : Coffin–Lowry syndrome MASA syndrome Alpha-thalassemia mental retardation syndrome Siderius X-linked mental retardation syndrome Eye disorders: Color blindness (red and green, but not blue) Ocular albinism ( 1 ) Norrie disease Choroideremia Other: Charcot–Marie–Tooth disease (CMTX2-3) Pelizaeus–Merzbacher disease SMAX2 Skin and related tissue Dyskeratosis congenita Hypohidrotic ectodermal dysplasia (EDA) X-linked ichthyosis X-linked endothelial corneal dystrophy Neuromuscular Becker's muscular dystrophy / Duchenne Centronuclear myopathy (MTM1) Conradi–Hünermann syndrome Emery–Dreifuss muscular dystrophy 1 Urologic Alport syndrome Dent's disease X-linked nephrogenic diabetes insipidus Bone / tooth AMELX Amelogenesis imperfecta No primary system Barth syndrome McLeod syndrome Smith–Fineman–Myers syndrome Simpson–Golabi–Behmel syndrome Mohr–Tranebjærg syndrome Nasodigitoacoustic syndrome X-linked dominant X-linked hypophosphatemia Focal dermal hypoplasia Fragile X syndrome Aicardi syndrome Incontinentia pigmenti Rett syndrome CHILD syndrome Lujan–Fryns syndrome Orofaciodigital syndrome 1 Craniofrontonasal dysplasia v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins v t e Pigmentation disorders / Dyschromia Hypo- / leucism Loss of melanocytes Vitiligo Quadrichrome vitiligo Vitiligo ponctué Syndromic Alezzandrini syndrome Vogt–Koyanagi–Harada syndrome Melanocyte development Piebaldism Waardenburg syndrome Tietz syndrome Loss of melanin / amelanism Albinism Oculocutaneous albinism Ocular albinism Melanosome transfer Hermansky–Pudlak syndrome Chédiak–Higashi syndrome Griscelli syndrome Elejalde syndrome Griscelli syndrome type 2 Griscelli syndrome type 3 Other Cross syndrome ABCD syndrome Albinism–deafness syndrome Idiopathic guttate hypomelanosis Phylloid hypomelanosis Progressive macular hypomelanosis Leukoderma w/o hypomelanosis Vasospastic macule Woronoff's ring Nevus anemicus Ungrouped Nevus depigmentosus Postinflammatory hypopigmentation Pityriasis alba Vagabond's leukomelanoderma Yemenite deaf-blind hypopigmentation syndrome Wende–Bauckus syndrome Hyper- Melanin / Melanosis / Melanism Reticulated Dermatopathia pigmentosa reticularis Pigmentatio reticularis faciei et colli Reticulate acropigmentation of Kitamura Reticular pigmented anomaly of the flexures Naegeli–Franceschetti–Jadassohn syndrome Dyskeratosis congenita X-linked reticulate pigmentary disorder Galli–Galli disease Revesz syndrome Diffuse/ circumscribed Lentigo / Lentiginosis : Lentigo simplex Liver spot Centrofacial lentiginosis Generalized lentiginosis Inherited patterned lentiginosis in black persons Ink spot lentigo Lentigo maligna Mucosal lentigines Partial unilateral lentiginosis PUVA lentigines Melasma Erythema dyschromicum perstans Lichen planus pigmentosus Café au lait spot Poikiloderma ( Poikiloderma of Civatte Poikiloderma vasculare atrophicans ) Riehl melanosis Linear Incontinentia pigmenti Scratch dermatitis Shiitake mushroom dermatitis Other/ ungrouped Acanthosis nigricans Freckle Familial progressive hyperpigmentation Pallister–Killian syndrome Periorbital hyperpigmentation Photoleukomelanodermatitis of Kobori Postinflammatory hyperpigmentation Transient neonatal pustular melanosis Other pigments Iron Hemochromatosis Iron metallic discoloration Pigmented purpuric dermatosis Schamberg disease Majocchi's disease Gougerot–Blum syndrome Doucas and Kapetanakis pigmented purpura / Eczematid-like purpura of Doucas and Kapetanakis Lichen aureus Angioma serpiginosum Hemosiderin hyperpigmentation Other metals Argyria Chrysiasis Arsenic poisoning Lead poisoning Titanium metallic discoloration Other Carotenosis Tar melanosis Dyschromia Dyschromatosis symmetrica hereditaria Dyschromatosis universalis hereditaria See also Skin color Skin whitening Tanning Sunless Tattoo removal Depigmentation
    IKBKG, NSDHL, COX8A, STAT6, IKBKGP1, TNF, TRAF6, EDA, IL4, TRIM13, TNFRSF1A, HAND2, NR1I3, AGT, GJB6, SPG7, SPIN2A, SHARPIN, CYCSP25, EDARADD, PROKR2, SIRT1, PRKAR1A, CCL11, AR, ARR3, CASP3, CASP9, CASR, CD38, CXADR, CYP1B1, G6PD, IFNA1, IFNA13, MPO, MUC1, NF2, NFKB1, PREP, CXADRP1
    • Incontinentia Pigmenti GeneReviews
      The differential diagnosis of other manifestations of IP includes the following disorders: Naegeli syndrome (OMIM 161000), a rare autosomal dominant disorder affecting the skin and skin derivatives, resembles IP, but also includes hyperhidrosis and punctate hyperkeratosis of the palms and soles. Unlike IP, Naegeli syndrome does not evolve through different stages of skin involvement. Naegeli syndrome is extremely rare; an individual with linear, wart-like lesions is more likely to have IP. Pathogenic variants in KRT14 cause Naegeli syndrome. Retinal neovascularization is observed in retinopathy of prematurity and familial exudative vitreoretinopathy, which can be inherited in an X-linked recessive manner as part of the Norrie disease spectrum (see OMIM 310600) or in an autosomal dominant manner (see Phenotypic Series: Exudative vitreoretinopathy).
    • Incontinentia Pigmenti OMIM
      By way of contrast, in the Aicardi syndrome (304050), X inactivation was apparently at random. ... IP in a male with XXY Klinefelter syndrome (Kunze et al., 1977) is consistent with this hypothesis. Ormerod et al. (1987) described incontinentia pigmenti in a boy with XXY Klinefelter syndrome. Pedigree patterns suggested X-linked dominance with lethality in the male.
    • Incontinentia Pigmenti Orphanet
      An X-linked syndromic muti-systemic ectodermal dysplasia presenting neonatally in females with a bullous rash along Blaschko's lines (BL) followed by verrucous plaques and hyperpigmented swirling patterns. ... Differential diagnosis of stage II includes warts, molluscum contagiosum, and epidermal nevus syndrome. Any condition with 'linear and swirled' pigmentation overlaps with stage III. ... Additional reported differential diagnoses are Naegeli-Franceschetti-Jadassohn syndrome and Norrie's disease. Antenatal diagnosis Fertility is normal except for the miscarriage of affected males.
    • Incontinentia Pigmenti MedlinePlus
      Incontinentia pigmenti is a condition that can affect many body systems, particularly the skin . This condition occurs much more often in females than in males. Incontinentia pigmenti is characterized by skin abnormalities that evolve throughout childhood and young adulthood. Many affected infants have a blistering rash at birth and in early infancy, which heals and is followed by the development of wart-like skin growths . In early childhood, the skin develops grey or brown patches (hyperpigmentation ) that occur in a swirled pattern. These patches fade with time, and adults with incontinentia pigmenti usually have lines of unusually light-colored skin (hypopigmentation) on their arms and legs.
    • Incontinentia Pigmenti GARD
      Incontinentia pigmenti (IP) is a genetic condition that affects the skin and other body systems. Skin symptoms change with time and begin with a blistering rash in infancy, followed by wart-like skin growths. The growths become swirled grey or brown patches in childhood, and then swirled light patches in adulthood. Other signs and symptoms may include hair loss, small or missing teeth, eye abnormalities that can lead to vision loss, and lined or pitted nails. Most people with IP have normal intelligence, but some have developmental delay, intellectual disability, seizures, and/or other neurological problems.
  • Seckel Syndrome Wikipedia
    Seckel syndrome Other names Harper's syndrome Specialty Medical genetics Seckel syndrome , or microcephalic primordial dwarfism (also known as bird-headed dwarfism , Harper's syndrome , Virchow–Seckel dwarfism and bird-headed dwarf of Seckel [1] ) is an extremely rare congenital nanosomic disorder. ... "Nephrolithiasis in a 17-Year-Old Male With Seckel Syndrome and Horseshoe Kidneys: Case Report and Review of the Literature". ... Springfield, Ill.: Charles C Thomas (pub.) 1960. ^ "Seckel's syndrome" . ^ Harper RG, Orti E, Baker RK (May 1967). "Bird-beaded dwarfs (Seckel's syndrome). A familial pattern of developmental, dental, skeletal, genital, and central nervous system anomalies". ... External links [ edit ] Seckel's syndrome at Who Named It? Classification D ICD - 10 : Q87.1 ICD - 9-CM : 759.89 OMIM : 210600 DiseasesDB : 31625 External resources Orphanet : 808 v t e Congenital abnormality syndromes Craniofacial Acrocephalosyndactylia Apert syndrome Carpenter syndrome Pfeiffer syndrome Saethre–Chotzen syndrome Sakati–Nyhan–Tisdale syndrome Bonnet–Dechaume–Blanc syndrome Other Baller–Gerold syndrome Cyclopia Goldenhar syndrome Möbius syndrome Short stature 1q21.1 deletion syndrome Aarskog–Scott syndrome Cockayne syndrome Cornelia de Lange syndrome Dubowitz syndrome Noonan syndrome Robinow syndrome Silver–Russell syndrome Seckel syndrome Smith–Lemli–Opitz syndrome Snyder–Robinson syndrome Turner syndrome Limbs Adducted thumb syndrome Holt–Oram syndrome Klippel–Trénaunay–Weber syndrome Nail–patella syndrome Rubinstein–Taybi syndrome Gastrulation / mesoderm : Caudal regression syndrome Ectromelia Sirenomelia VACTERL association Overgrowth syndromes Beckwith–Wiedemann syndrome Proteus syndrome Perlman syndrome Sotos syndrome Weaver syndrome Klippel–Trénaunay–Weber syndrome Benign symmetric lipomatosis Bannayan–Riley–Ruvalcaba syndrome Neurofibromatosis type I Laurence–Moon–Bardet–Biedl Bardet–Biedl syndrome Laurence–Moon syndrome Combined/other, known locus 2 ( Feingold syndrome ) 3 ( Zimmermann–Laband syndrome ) 4 / 13 ( Fraser syndrome ) 8 ( Branchio-oto-renal syndrome , CHARGE syndrome ) 12 ( Keutel syndrome , Timothy syndrome ) 15 ( Marfan syndrome ) 19 ( Donohue syndrome ) Multiple Fryns syndrome v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins v t e Nucleus diseases Telomere Revesz syndrome Nucleolus Treacher Collins syndrome Spinocerebellar ataxia 7 Cajal body : Spinal muscular atrophy Centromere CENPJ Seckel syndrome 4 Other AAAS Triple-A syndrome Laminopathy SMC1A / SMC3 Cornelia de Lange Syndrome SETBP1 Schinzel–Giedion syndrome see also nucleus
    ATR, CENPJ, PCNT, ATRIP, TRAIP, CENPE, PLK4, CEP152, DNA2, LIG4, WDR4, RBBP8, ORC1, ORC4, IGF1, XRCC4, ORC6, DNMT3A, GMNN, CENPF, CDC6, CDT1, LZTR1, KRAS, PTPN11, RAF1, CEP63, SOS1, RIT1, RTTN, NIN, ATM, AIMP2, GRAP2, BRCA1, CD5L, CD69, MCPH1, CHEK1, LARP7, CRK, MAPK14, DONSON, POLDIP2, DNMT1, RNF19A, FANCA, FANCC, PNKP, FAH, H2AX, AHSA1, MAPK1, TELO2, CEP135, TUBGCP6
    • Seckel Syndrome GARD
      Seckel syndrome is a genetic disorder characterized by growth retardation, very small head (microcephaly( with intellectual disability , and unique facial features such as large eyes, beak-like nose, narrow face, and receding lower jaw. About less than 25% of the patients also have blood abnormalities. Seckel syndrome is inherited in an autosomal recessive fashion.
    • Microcephaly 13, Primary, Autosomal Recessive OMIM
      A number sign (#) is used with this entry because of evidence that autosomal recessive primary microcephaly-13 (MCPH13) is caused by compound heterozygous mutation in the CENPE gene (117143) on chromosome 4q24. One such family has been reported. For a phenotypic description and a discussion of genetic heterogeneity of primary microcephaly, see MCPH1 (251200). Clinical Features Mirzaa et al. (2014) reported a brother and sister, born of unrelated parents of European descent, with microcephaly, poor overall growth, and developmental delay. Both had intrauterine growth retardation and microcephaly apparent on prenatal ultrasound, as well as similar dysmorphic facial features, including sloping forehead, prominent nose, and mild micrognathia. At age 5 years, the older sib, a boy, had microcephaly (-9 SD), short stature (-7 SD), small hands and feet, mild spasticity, and severely delayed psychomotor development with absent speech and poor gross and fine motor skills.
    • Seckel Syndrome Orphanet
      Seckel syndrome is a type of microcephalic primordial dwarfism that is characterized by a proportionate dwarfism of prenatal onset, a severe microcephaly, a typical dysmorphic face (bird-like), and mild to severe intellectual disability.
    • Seckel Syndrome 1 OMIM
      The report of a Seckel syndrome locus on chromosome 14q, designated SCKL3, by Kilinc et al. (2003) was found to be in error; see History section. ... Although some patients with Seckel syndrome manifest anemia and other hematologic abnormalities, AML had not previously been reported. Hayani et al. (1994) suggested that patients with Seckel syndrome may be at risk of developing myelodysplasia and AML. ... Heterogeneity Faivre et al. (2002) confirmed the heterogeneity of Seckel syndrome by excluding the previously mapped loci on chromosomes 3 and 18 in 5 consanguineous and 1 multiplex nonconsanguineous Seckel syndrome families. ... Associations Pending Confirmation For discussion of a possible association between Seckel syndrome and variation in the ATRIP gene, see 606605.0001.
    • Seckel Syndrome 9 OMIM
      A number sign (#) is used with this entry because of evidence that Seckel syndrome-9 (SCKL9) is caused by homozygous mutation in the TRAIP gene (605958) on chromosome 3p21. For a general phenotypic description and a discussion of genetic heterogeneity of Seckel syndrome, see SCKL1 (210600). Clinical Features Silengo et al. (2001) described 2 Italian sibs with a Seckel-like malformation syndrome characterized by intrauterine growth retardation (IUGR), microcephaly, beaked nose, failure to thrive, and early death. ... Additional whole-exome sequencing in 28 patients with a presumptive diagnosis of Seckel syndrome identified a Turkish boy who was homozygous for a missense mutation (R18C; 605958.0002) in the TRAIP gene.
    • Microcephaly And Chorioretinopathy, Autosomal Recessive, 2 OMIM
      Shaheen et al. (2014) noted the phenotypic similarities to Seckel syndrome (SCKL1; 210600). Inheritance The transmission pattern of MCCRP2 in the families reported by Martin et al. (2014) was consistent with autosomal recessive inheritance.
    • Seckel Syndrome 2 OMIM
      A number sign (#) is used with this entry because of evidence that Seckel syndrome-2 (SCKL2) is caused by homozygous mutation in the RBBP8 gene (604124) on chromosome 18q11. Jawad syndrome (251255), a microcephaly syndrome involving mental retardation and digital anomalies, is also caused by mutation in the RBBP8 gene. ... For a general phenotypic description and a discussion of genetic heterogeneity of Seckel syndrome, see SCKL1 (210600). Clinical Features Borglum et al. (2001) studied a consanguineous family of Iraqi descent with Seckel syndrome. The parents were first cousins and had 4 children who fulfilled the criteria for Seckel syndrome, as well as a younger healthy girl. ... In a 9-year-old Saudi Arabian girl with Seckel syndrome, Shaheen et al. (2014) identified homozygosity for a missense mutation in the RBBP8 gene (R100W; 604124.0004).
    • Intrauterine Growth Retardation With Increased Mitomycin C Sensitivity OMIM
      Woods et al. (1995) reported the case of an infant with pre- and postnatal microcephaly and growth retardation, a distinctive face, and developmental delay. Seckel syndrome was the initial diagnosis. The infant became pancytopenic at 16 months of age and died soon thereafter. ... Woods et al. (1995) proposed that this infant suffered from a distinct chromosome breakage syndrome. They found at least 7 reported cases of Seckel-like intrauterine growth retardation with pancytopenia, including 2 sibs in Seckel's original publication (Seckel, 1960). Other cases were reported by Upjohn (1955) and Butler et al. (1987). Because Seckel syndrome is likely to be heterogeneous, Woods et al. (1995) preferred to refer to the disorder they reported as 'severe intrauterine growth retardation with increased mitomycin C sensitivity.'
    • Seckel Syndrome 8 OMIM
      A number sign (#) is used with this entry because of evidence that Seckel syndrome-8 (SCKL8) is caused by homozygous mutation in the DNA2 gene (601810) on chromosome 10q21. One such family has been reported. Description Seckel syndrome is a rare autosomal recessive disorder characterized by intrauterine growth retardation, dwarfism, microcephaly with mental retardation, and a characteristic 'bird-headed' facial appearance (summary by Shanske et al., 1997). For a discussion of genetic heterogeneity of Seckel syndrome, see SCKL1 (210600). Clinical Features Shaheen et al. (2014) studied an uncle and niece, both born of consanguineous marriages, with short stature and strikingly similar facial features consistent with Seckel syndrome. ... Molecular Genetics In an uncle and niece with short stature and strikingly similar facial features consistent with Seckel syndrome, Shaheen et al. (2014) performed autozygome analysis and found a single shared run of homozygosity on chr10:63,850,661-71,470,390 (GRCh37).
    • Seckel Syndrome 5 OMIM
      A number sign (#) is used with this entry because Seckel syndrome-5 is caused by homozygous or compound heterozygous mutation in the CEP152 gene (613529) on chromosome 15q21. ... For a general phenotypic description and a discussion of genetic heterogeneity of Seckel syndrome, see 210600. Clinical Features Kalay et al. (2011) clinically evaluated 5 consanguineous families with Seckel syndrome originating from an isolated rural area in Turkey. ... Cranial magnetic resonance imaging in 2 patients showed simplified gyri. Inheritance Seckel syndrome-5 is an autosomal recessive disorder (Kalay et al., 2011). Mapping Using SNP array homozygosity mapping in 4 affected members of 3 Turkish families segregating Seckel syndrome, Kalay et al. (2011) obtained a lod score of 6.03 on chromosome 15q21.1-q21.2. ... By sequence analysis, Kalay et al. (2011) also identified compound heterozygous mutations in the CEP152 gene in affected Seckel syndrome patients of different ethnic origins (613529.0004-613529.0007).
    • Seckel Syndrome 4 OMIM
      A number sign (#) is used with this entry because of evidence that Seckel syndrome-4 (SCKL4) is caused by homozygous mutation in the CENPJ gene (609279) on chromosome 13q12. ... For a general description and a discussion of genetic heterogeneity of Seckel syndrome, see 210600. Clinical Features Al-Dosari et al. (2010) described a consanguineous Saudi family in which several members had clinical features of Seckel syndrome. ... Inheritance Consanguinity and affected sibs in the family with Seckel syndrome reported by Al-Dosari et al. (2010) were consistent with autosomal recessive inheritance. Mapping By homozygosity mapping and linkage analysis in a Saudi family with Seckel syndrome, Al-Dosari et al. (2010) mapped the locus for the disorder to chromosome 13q12 (maximum lod of 3.4). Molecular Genetics In affected members of a Saudi family segregating Seckel syndrome, Al-Dosari et al. (2010) identified a homozygous splicing mutation in the last nucleotide of intron 11 of the CENPJ gene (IVS11-1G-C; 609279.0004).
  • Pallister–hall Syndrome Wikipedia
    Unsourced material may be challenged and removed. Find sources: "Pallister–Hall syndrome" – news · newspapers · books · scholar · JSTOR ( August 2011 ) ( Learn how and when to remove this template message ) Pallister–Hall syndrome (PHS) Pallister–Hall syndrome is inherited in an autosomal dominant pattern. Specialty Medical genetics Pallister–Hall syndrome (abbreviated PHS) [1] is a disorder that affects the development of many parts of the body. ... Defects in the same gene also cause Greig cephalopolysyndactyly syndrome . Mutations that cause Pallister–Hall syndrome typically lead to the production of an abnormally short version of the GLI3 protein. ... You can help by adding to it . ( December 2017 ) Notable Cases [ edit ] George William Helon (Australian author and businessman) is a Pallister-Hall Syndrome (PHS) patient, mentor, counsellor and advocate. [4] [5] [6] References [ edit ] ^ https://rarediseases.info.nih.gov/diseases/7305/pallister-hall-syndrome ^ synd/506 at Who Named It? ... v=AZGwNBguEl0&t=51s ^ https://drive.google.com/file/d/1OmvV07NoZo-oygxIjqMwncKfc6DL4htW/view Pallister–Hall syndrome at NLM Genetics Home Reference External links [ edit ] Classification D ICD - 10 : D33.0 OMIM : 146510 MeSH : D054975 DiseasesDB : 32013 GeneReviews/NCBI/NIH/UW entry on Pallister–Hall Syndrome Genetics Home Reference v t e Genetic disorders relating to deficiencies of transcription factor or coregulators (1) Basic domains 1.2 Feingold syndrome Saethre–Chotzen syndrome 1.3 Tietz syndrome (2) Zinc finger DNA-binding domains 2.1 ( Intracellular receptor ): Thyroid hormone resistance Androgen insensitivity syndrome PAIS MAIS CAIS Kennedy's disease PHA1AD pseudohypoaldosteronism Estrogen insensitivity syndrome X-linked adrenal hypoplasia congenita MODY 1 Familial partial lipodystrophy 3 SF1 XY gonadal dysgenesis 2.2 Barakat syndrome Tricho–rhino–phalangeal syndrome 2.3 Greig cephalopolysyndactyly syndrome / Pallister–Hall syndrome Denys–Drash syndrome Duane-radial ray syndrome MODY 7 MRX 89 Townes–Brocks syndrome Acrocallosal syndrome Myotonic dystrophy 2 2.5 Autoimmune polyendocrine syndrome type 1 (3) Helix-turn-helix domains 3.1 ARX Ohtahara syndrome Lissencephaly X2 MNX1 Currarino syndrome HOXD13 SPD1 synpolydactyly PDX1 MODY 4 LMX1B Nail–patella syndrome MSX1 Tooth and nail syndrome OFC5 PITX2 Axenfeld syndrome 1 POU4F3 DFNA15 POU3F4 DFNX2 ZEB1 Posterior polymorphous corneal dystrophy Fuchs' dystrophy 3 ZEB2 Mowat–Wilson syndrome 3.2 PAX2 Papillorenal syndrome PAX3 Waardenburg syndrome 1&3 PAX4 MODY 9 PAX6 Gillespie syndrome Coloboma of optic nerve PAX8 Congenital hypothyroidism 2 PAX9 STHAG3 3.3 FOXC1 Axenfeld syndrome 3 Iridogoniodysgenesis, dominant type FOXC2 Lymphedema–distichiasis syndrome FOXE1 Bamforth–Lazarus syndrome FOXE3 Anterior segment mesenchymal dysgenesis FOXF1 ACD/MPV FOXI1 Enlarged vestibular aqueduct FOXL2 Premature ovarian failure 3 FOXP3 IPEX 3.5 IRF6 Van der Woude syndrome Popliteal pterygium syndrome (4) β-Scaffold factors with minor groove contacts 4.2 Hyperimmunoglobulin E syndrome 4.3 Holt–Oram syndrome Li–Fraumeni syndrome Ulnar–mammary syndrome 4.7 Campomelic dysplasia MODY 3 MODY 5 SF1 SRY XY gonadal dysgenesis Premature ovarian failure 7 SOX10 Waardenburg syndrome 4c Yemenite deaf-blind hypopigmentation syndrome 4.11 Cleidocranial dysostosis (0) Other transcription factors 0.6 Kabuki syndrome Ungrouped TCF4 Pitt–Hopkins syndrome ZFP57 TNDM1 TP63 Rapp–Hodgkin syndrome / Hay–Wells syndrome / Ectrodactyly–ectodermal dysplasia–cleft syndrome 3 / Limb–mammary syndrome / OFC8 Transcription coregulators Coactivator: CREBBP Rubinstein–Taybi syndrome Corepressor: HR ( Atrichia with papular lesions ) v t e Phakomatosis Angiomatosis Sturge–Weber syndrome Von Hippel–Lindau disease Hamartoma Tuberous sclerosis Hypothalamic hamartoma ( Pallister–Hall syndrome ) Multiple hamartoma syndrome Proteus syndrome Cowden syndrome Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Neurofibromatosis Type I Type II Other Abdallat–Davis–Farrage syndrome Ataxia telangiectasia Incontinentia pigmenti Peutz–Jeghers syndrome Encephalocraniocutaneous lipomatosis
    GLI3, SOX2, KIF7, FAM149B1, CPLANE1, TMEM216, SIX6, PDE6D, TCTN3, KIAA0753, OFD1, SLC12A5, GJD2, SMUG1, MCF2L, TGFA, ADARB1, SMO, SLC25A4, MAPK3, PRKACA, POU3F4, PLCG1, NUP98, LRP2, GJA1, BDNF, SLC25A6, MAPK8
    • Hypothalamic Hamartomas OMIM
      A third was associated with malformations suggestive of Meckel syndrome (249000): heart defect, pulmonary hypoplasia, renal dysplasia, and posterior encephalocele. ... Encha-Razavi et al. (1992) suggested the designation congenital hypothalamic hamartoma syndrome (CHHS) for a possibly familial disorder that combines orofacial abnormalities and skeletal dysplasia with hypothalamic hamartomas. ... Because approximately 5% of cases of hypothalamic hamartomas are associated with Pallister-Hall syndrome (PHS; 146510), which is caused by haploinsufficiency of GLI3, Craig et al. (2008) investigated the possibility that HH pathogenesis in sporadic cases is due to a somatic mutation in GLI3.
    • Pallister-Hall Syndrome OMIM
      The conditions that they considered as related included Smith-Lemli-Opitz syndrome (270400), the pseudotrisomy 13 syndrome or holoprosencephaly-polydactyly syndrome (264480), orofaciodigital syndrome type VI or Varadi-Papp syndrome (277170), and the hydrolethalus syndrome (236680). ... Donnai et al. (1987) had suggested that the Pallister-Hall syndrome and severe Smith-Lemli-Opitz syndrome (270400) are the same disorder. Using multivariate analysis and numerical taxonomy, Verloes et al. (1995) concluded that on review, 'most overlapping cases (and, in fact, most cases reported as Pallister-Hall, including some from the original report)' could be unambiguously classified as Smith-Lemli-Opitz syndrome, orofaciodigital syndrome type VI (277170), or holoprosencephaly-polydactyly syndrome (264480). ... The radiologic abnormalities in the hand are helpful in differentiating Pallister-Hall syndrome from other syndromes in which hypothalamic hamartoblastoma is observed. ... Lurie (1995) questioned whether the Kaufmann-McKusick syndrome and the Pallister-Hall syndrome can be considered one entity.
    • Tuber Cinereum Hamartoma Wikipedia
      Other symptoms of this tumor type include visual disturbances, such as the appearance of motion from a stationary object, or inappropriate color perception of the entire visual field. [6] Associated conditions [ edit ] Tuber cinereum hamartoma may be associated with Pallister-Hall syndrome , a diagnosis characterized by multiple malformations, including polydactyly and imperforate anus . ... External links [ edit ] Images of Hypothalamic Hamartoma v t e Phakomatosis Angiomatosis Sturge–Weber syndrome Von Hippel–Lindau disease Hamartoma Tuberous sclerosis Hypothalamic hamartoma ( Pallister–Hall syndrome ) Multiple hamartoma syndrome Proteus syndrome Cowden syndrome Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Neurofibromatosis Type I Type II Other Abdallat–Davis–Farrage syndrome Ataxia telangiectasia Incontinentia pigmenti Peutz–Jeghers syndrome Encephalocraniocutaneous lipomatosis v t e Physiology of the endocrine system Regulatory systems Hypothalamic–pituitary–thyroid axis Hypothalamic–pituitary–adrenal axis Hypothalamic–pituitary–gonadal axis Hypothalamic–pituitary–somatotropic axis Hypothalamic–pituitary–prolactin axis Hypothalamic–neurohypophyseal system Renin–angiotensin system Metabolism Blood sugar regulation Calcium metabolism Fields Neuroendocrinology Pediatric endocrinology Psychoneuroendocrinology Reproductive endocrinology and infertility Other Wolff–Chaikoff effect / Jod-Basedow effect v t e Tumours of endocrine glands Pancreas Pancreatic cancer Pancreatic neuroendocrine tumor α : Glucagonoma β : Insulinoma δ : Somatostatinoma G : Gastrinoma VIPoma Pituitary Pituitary adenoma : Prolactinoma ACTH-secreting pituitary adenoma GH-secreting pituitary adenoma Craniopharyngioma Pituicytoma Thyroid Thyroid cancer (malignant): epithelial-cell carcinoma Papillary Follicular / Hurthle cell Parafollicular cell Medullary Anaplastic Lymphoma Squamous-cell carcinoma Benign Thyroid adenoma Struma ovarii Adrenal tumor Cortex Adrenocortical adenoma Adrenocortical carcinoma Medulla Pheochromocytoma Neuroblastoma Paraganglioma Parathyroid Parathyroid neoplasm Adenoma Carcinoma Pineal gland Pinealoma Pinealoblastoma Pineocytoma MEN 1 2A 2B
    • Hypothalamic Hamartomas GARD
      Though hypothalamic hamartomas can occur in patients with certain genetic disorders (such as Pallister-Hall syndrome ), the majority of cases are sporadic.
  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 556
  • 557
  • →

FindZebra

contact@findzebra.com